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PREFACE.
This work was carried out during my appointment as 
Resident Physician at Knightswood Hospital, Glasgow, and extends 
over the period December 1937 to March 1939.
The sputum of all pneumonia patients admitted to 
Knightswood Hospital is typed for statistical purposes, so this 
was pursued as a routine procedure on taking charge of the 
pneumonia wards.
Later, it was decided to make a study of the prognostic 
significance of the variable factors which tend to influence the 
outcome of pneumonia, particular attention being paid to the 
Schilling Count.
By September 1938, 67 patients in all had been 
investigated along these lines, when Sulphapyridine was made 
generally available for use in the hospital. A series of 90 
patients was treated with the new drug and an attempt made to 
assess the efficacy of the new treatment by comparing the results 
obtained, with those in the 67 patients treated before the advent 
of Sulphapyridine.
I am deeply indebted to Dr.William Dow, Medical 
Superintendent of Knightswood Hospital for his never failing 
interest and encouragement throughout this investigation. I 
would also like to thank the nursing staff and Miss A.N.McIntosh 
for their co-operation, both in the hospital wards and laboratory.
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INTRODUCTION.
The concentration of patients suffering from 
pneumococcal lobar pneumonia in Infectious Disease Hospitals 
in recent years (as opposed to the former practice of treating 
such patients in General Hospitals) has facilitated the 
exploration of many features of the clinical epidemiology of 
this particular disease. The present investigation deals with 
several aspects of this, in particular a description of the 
prevalent local type distribution of the infecting organisms 
and the contrast which this forms with figures from other 
countries; the influence of varying type distribution on 
recorded crude fatality rates; the haemotological picture at 
the commencement and the changes in this respect during the 
currency of the illness; the frequency of discoverable bacteraemia 
in patients with reference to type of infecting organisms; the 
prognostic significance of various clinical data and in particular 
the difference in response to treatment by recently introduced 
chemotherapeutic agents, compared with the immediately antecedent 
general methods in vogue.
While the segregation of an appreciable proportion of 
victims of any disease in a particular type of hospital facilitates 
investigation, it does not by any means eliminate the difficulties. 
In this research, for example, I have included all the cases coming 
under my notice over a period of fifteen months (from December, 
1937, to March 1938) and yet my results are in some respects 
inconclusive when appropriate analysis is applied to my data. 
Whether the minor differences observed in several instances are 
merely chance fluctuations (as I have perforce concluded) or 
whether with more extensive data these differences could have 
been regarded as of significance, one cannot judge; but the desire 
for a larger basis of fact (to be obtained within a reasonable
period of time) leaves me to emphasise the need, in a locality 
such as Glasgow, for a pooling by all hospitals of the data 
relevant to the solution of predetermined outlined problems in 
many fields of clinical medicine, and a consequent speedier and 
more certain arrival at the desired goal. Much of the published 
data lacks the solid basis of facts and superstructure of detailed 
analysis. The consequent waste of individual time and energy 
(together with the virtual loss of vital data) strikingly 
indicates the need for expert direction of the young researcher 
and the altruistic pooling of material collected on similar lines.
Pneumonia, it need scarcely be emphasised, is one of 
the major problems of present-day public health. While numer­
ically less outstanding than, for example, cancer or 
cardiovascular diseases, it still is a leading cause of death, 
accounting for, in Scotland (1938), 3832 deaths, out of a total 
of 62,953, i.e. for one out of sixteen deaths, in a year, it 
should be noted, when mortality from the disease was the lowest 
recorded since 1871. Moreover, the trend of mortality from this 
cause has not, as with many other causes of death, been very 
favourable, recorded mortality from the beginning of the present 
century in Scotland being as follows:
Period
Death Rate 
Pneumonia
per 100,000 
Tuberculosis
1901-5 146 218
1906-10 144 204
1911-15 129 169
1916-20 177 147
1921-25 131 117
1926-30 137 96
1931-35 110 80
1936 103 74
1937 123 74
1938 80 69
III.
For contrast, I have inserted the corresponding death 
rates for tuberculosis (all forms), a disease which at the 
outset of this century showed a rate of mortality half as high 
again as pneumonia, whereas by the year 1938, it showed a rate 
some 15 per cent lower.
Pneumonia, heretofore at least, had the highest 
fatality of the infectious diseases common to this country. In 
the special section of my thesis, attempting an appraisal of the 
more up-to-date therapeutic procedures, I have indicated that 
this high fatality rate is, for purposes of investigation, 
fortunate since this forms a convenient single expression of 
response to treatment. Contrast the position if evaluation of 
therapy was in respect of a disease such as scarlet fever with 
a fatality rate of one per cent or less. If this were the index 
of response to treatment, the number of cases required to arrive 
at a significant result would need to be so much greater that 
time alone would have prevented the enquiry. If the unique 
index of a death rate were not available and acceptable, judg­
ment would require to be based on such less easily assessed 
factors as, for example, duration of illness incidence of various 
complications, wherein personal assessments intervene and lack 
of comparability is liable to arise.
The descriptive part of the following work, type 
distribution of the infecting organisms and blood findings, 
requires no preliminary explanation,but for the therapeutic 
assessment I was forced to undertake a preliminary study of 
prognostic factors in pneumonia. The reason for this was that 
I was not in the happy position of carrying out an ideal approach 
to the subject, whereby two contemporaneous series of cases could 
be treated by alternative methods. The results and description 
of 67 cases of the disease treated by general methods with or 
without anti-pneumococcal serum had already been collected before
IV.
chemotherapy was brought into general use. I decided, therefore, 
with the limited time and restricted number of cases likely to 
be available to me, to use these cases as a background and all 
subsequent cases were subjected to the new therapy. The 
comparison thus introduces the possible criticism of lack of 
contemporaneity but I believe I have averted or answered any 
criticism in this respect by showing that the two groups of 
cases do not differ effectively so far as can be judged by 
assessment of initial severity of the two groups of cases based 
on prognostic data. To obtain these prognostic factors, I have 
compared the initial findings in patients who ultimately die 
and who ultimately recover and it seems reasonable that the 
initial findings are, in some way, correlated with the final 
outcome. The findings here, I regard as of general utility as 
providing for other observers a method, superior to clinical 
judgment, of assessing initial severity - a method, moreover, 
which largely excludes the effect of individual variations of 
judgment. The factors which influence the outcome are:- age 
of patient, type of infecting pneumococcus, extent of lung 
involvenent, presence of bacteraemia, degree of "shift to left" 
in Schilling count.
The general result of my assessment of the effect of 
Sulphapyridine on the mortality from pneumococcal pneumonia, 
while suggestive of a beneficial influence of the drug, is not 
nearly of so optimistic a character as other observers1 results 
would suggest. Series of cases, of the same dimension as my 
own, have been recorded by various writers who, in some instances, 
have shown a mortality rate, as low as one or two per cent. 
Another finding, which so far has not been stressed, is that 
Sulphapyridine seems to exert a certain degree of type specific 
action, the beneficient effects being rather more apparent in 
Type II. infections.
THE CLASSIFICATION AND ISOLATION OF THE PNEUMOCOCCUS 
(TYPES I.-XXXII.) FROM CASES OF PNEUMOCOCCAL PNEUMONIA.
THE CLASSIFICATION AND ISOLATION OF THE PNEUMOCOCCUS 
(TYPES I.-XXXII.) FROM CASES OF PNEUMOCOCCAL PNEUMONIA.
The earliest classification of the pneumococcus can 
he traced to the year 1897, when Bezancon and Griffin, as a 
result of the discovery that antipneumococcal serum had agglu­
tinative properties, reported that there existed several strains 
of pneumococci, which differed serologically. Their findings 
were based on the fact, up until then unknown, that sera prepared 
from a certain strain would agglutinate pneumococci isolated 
from some patients suffering from pneumonia but not from others. 
They also observed marked agglutination between the serum of 
certain patients and the particular organism causing the in­
fection.
Some years later, Eyre and Washbourn (1899), by inject­
ing mice with both the organism and serum, showed that in addition 
to agglutinative properties, antipneumococcal serum had also 
protective powers.
It was not until 1910, however, that an attempt was 
made to separate the pneumococcus into the various types with 
which we are now familiar. The first work in this connection 
was done by Neufeld and Handel (1910), who, by immunising horses 
and rabbits, prepared a serum which protected against the majority 
of the prevalent strains of pneumococci. The strain from which 
this serum was prepared was designated by them Type I. Of the 
remaining strains which did not conform to Type I., the most 
commonly recurring was the "Franz” strain, which was later 
identified to be the same as Dochez and Gillespiefs Type II.
These two American workers succeeded in 1913 in classifying the 
pneumococcus by both agglutinative and mouse protection methods 
into Types I., II. and III. A number of heterogeneous and
3unclassified strains were termed Group IV. pneumococci.
In 1932, Cooper et al.were successful in dividing the 
heterogeneous Group IV. into a further 29 types (Types I.-XXXII.). 
Since then it has been proved that Types VI. and XXVI. are 
identical with Types XV. and XXX. respectively, with the result 
that pneumococci are now classified into 30 known types. Cooper 
and her colleagues, however, encountered several strains of 
pneumococcus which did not conform to any of these known types. 
This was also the experience of Sutllff and Finland, (1933). In 
this investigation, only four organisms failed to conform to any 
of the known types and these are referred to collectively as 
Type XXXIII.
Because it is known that the severity of pneumonia 
varies with the type of infecting organism, it has been the 
practice for the past eight years in Knightswood Hospital,
Glasgow, to type the pneumococcus from the sputa of all patients 
who have been admitted to hospital suffering from pneumococcal 
pneumonia. The method employed for typing these sputa has been 
that of Sabin (1933) with the modification that instead of 
examining the peritoneal exudate of the mice injected with sputa 
after an interval of four hours, the mice have been allowed to 
die before the examination took place. By this procedure the 
pneumococci were classified into Types I., II. and III. and 
these organisms which failed to agglutinate with Types I., II. 
and III. antisera, were classified under the collective heading, 
Group IV.
It will be the object of this Chapter to survey in 
detail the incidence of pneumococci Types I.-XXXII. in 200 
consecutive cases of pneumococcal pneumonia admitted to 
Knightswood Hospital from December, 1937, to March, 1939, but 
in order that the investigation might be complete, the work done
4on pneumococcal typing prior to that period is analysed in Table
I. below.
TABLE I .
TYPE OP INFECTING ORGANISMS IN PNEUMOCOCCAL PNEUMONIA.
Period
of
Investi- 
gat ion
Numbers and 
Mortality Rates Total
Type
I.
Type
II.
Type
III.
Group
IV.
1933
Knightswood Hospital 
Percentage of Total 
De aths
Case Mortality per Cent
47
27.3
6
12.7
71
41.2
15
21.1
10
5.8
6
60
44
25.5 
6
13.5
172
33
19.1
1934
Knightswood Hospital 
Percentage of Total 
Deaths
Case Mortality per Cent
36
29.2
2
5.5
41
33.3 
10
24.3
5
4.1
5
100
41
33.3
4
9.7
123
21
17.07
1935
Knightswood Hospital 
Percentage of Total 
Deaths
Case Mortality per Cent
28
23.9
1
3.5
44
37.6
8
18.1
7
5.9
2
28.5
38
32.4
2
5.2
117
13
11.1
1936
Knightswood Hospital 
Percentage of Total 
Deaths
Case Mortality per Cent
20
29.9
2
10
30
44.8
10
33.3
4
5.9
1
25
13
19.4
4
30.8
67
17
25.4
1937
Knightswood Hospital 
Percentage of Total 
Deaths
Case Mortality per Cent
36
26.08
3
8.3
52
37.6
32
61.5
20
14.4
17
85
30
21.7
12
40
138
64
46.3
1938
Knightswood Hospital 
Percentage of Total 
Deaths
Case Mortality per Cent
32
23.7
1
3.1
58
42.9
16
27.5
10
7.4
6
60
35
25.9
8
22.8
135
31
22.9
Total Cases 
Percentage of Total 
Total Deaths 
Case Mortality per Cent
199
26.4
15
7.5
296
39.3
91
30.7
56
7.4
37
66.07
201
26.7
36
17.9
752
179
23.8
Examination of the Table reveals two facts which are 
already well known, namely, that Type II. pneumococcal pneumonia 
is the most prevalent form encountered in Knightswood Hospital 
and that Type III. is the most fatal, but perhaps the most strik 
ing feature is the variability in the fatality rate from year to 
year without any marked variations in the type of infecting
5organism. This variability of fatality rate must be borne in 
mind when attempting to assess the efficacy of a new treatment 
of the disease and is discussed in Chapter III.
The older method of pneumococcal typing by agglutinat­
ing sera has given way to that of typing by capsular swelling, 
nowadays almost universally employed. This method is based on 
the work of Neufeld, who in 1902, described the Neufeld reaction 
characterised by the swelling of the capsule of the pneumococcus 
when placed in contact with the corresponding antiserum. Etinger- 
Tulczynska (1931) utilised this reaction in order to type the 
pneumococcus as quickly as possible but, in this country, rapid 
typing was not adopted until 1932, when a slightly modified method 
was introduced by Armstrong, and by Logan and Smeall. A year 
later, Goodner and Sabin (1933) advocated the use of rabbit in­
stead of horse serum because of its greater specificity, and since 
then rapid typing has been universally adopted. In December,
1937, it was made possible in this hospital, by the use of anti­
sera supplied by the Lederle Laboratories, to isolate the pneu­
mococcus into Types I.-XXXII. by the method of capsular swelling.
The antisera are supplied in small bottles containing
0.5 c.c. each, already tinted with Methylene Blue and to facili­
tate typing they are manufactured in composite form in six bottles 
labelled A, B, C, D, E and P.
Bottle A contains Types I., II. and VII.
" B " " III., IV., V., VI. and VIII.
" C " " IX., XII., XIV. and XVII.
" D " " X., XI., XIII., XX., XXII. and XXIV.
" E 1 " XVI., XVIII., XIX., XXI. and XXVII.
" F " " XXIII., XXV., XXVII., XXIX., XXXI. and
XXXII.
The methods employed and the results of typing by the 
Neufeld Reaction are detailed below.
6I. PNEUMOCOCCAL TYPING DIRECTLY FROM SPUTUM.
In all the cases which came under review, six flecks 
of sputum, preferably rusty, were transferred to a glass slide 
by means of a platinum loop,and after the addition of a loopful 
of the mixtures A, B, C, D, E and P, small coverglasses of 
diameter were applied and the slides examined under an oil im­
mersion lens. The advantage of using the small coverglasses was 
twofold, in that the pneumococci were localised to a small area 
thereby facilitating identification, and at the same time enabling 
the six preparations to be placed on the same slide.
The Neufeld Reaction or a positive reaction was easily 
recognised, but care had to be exercised to exclude the possibility 
of mistaking pneumococci with swollen capsules for yeast or starch 
granules. It had to be remembered also that a light halo normally 
appears around the organisms due to refraction from the capsules.
If the Neufeld Reaction was observed in A or B, it was 
essential to examine the remaining four preparations, as the 
possibility of more than one Type of pneumococcus being present 
had to be borne in mind.
If the Neufeld Reaction was not seen to occur in any 
of the six preparations, the slide was re-examined after an 
interval of 15-30 minutes in case the reaction was delayed.
When the pneumococcus had been assigned to one of the 
groups, the individual members of the particular group were then 
tested in a similar manner and so by a process of elimination the 
organism was finally typed. Before regarding the organism as un- 
typable, the sputum was tested against each individual antiserum 
in turn.
II. PNEUMOCOCCAL TYPING BY MOUSE INOCULATION.
After direct typing had been attempted, 1 c.c. of
7sputum was injected into the peritoneal cavity of a mouse which, 
depending on the virulence of the organism, died within 12 to 24 
hours. If for any reason, e.g. the treatment of the patient with 
type specific antipneumococcal serum, speed was essential and 
rapid typing had failed to reveal the type of infecting organism, 
the peritoneal exudate was examined in four hours as advocated 
by Sabin, by withdrawing a little peritoneal fluid through a 
sharp, fine-bore needle.
As the inoculation of a mouse was carried out mainly 
for confirmatory results, it was allowed to die and was dissected 
under aseptic precautions. Either the peritoneal fluid or heart 
blood, and in some cases both, were used for typing purposes and 
the technique was similar to that employed in the direct method, 
with the variation that six drops of peritoneal fluid or heart 
blood were mixed with the antisera instead of six flecks of sputa.
m .  PNEUMOCOCCAL TYPING FROM BLOOD CULTURE.
During this investigation, blood cultures were performed 
on 165 cases, some daily and others at intervals of 2-3 days, 
until the time of recovery or death. The medium used was Hartley*a 
Broth, put up in flasks, each flask containing 75 c.c. 10 c.c. of 
the patient’s blood were withdrawn from one of the arm veins and 
2 c.c. were added to 15 c.c. melted Agar (temperature 40 degrees 
Centigrade), in a test tube, mixed thoroughly and poured on to a 
Petri Dish. The remainder of the blood was then transferred to 
the flask of Broth. Both were incubated at 37 degrees Centigrade 
and examined microscopically after 24 hours’ incubation and at 
daily intervals for three days. If there was any indication of 
pneumococcal growth, the organism was tested against the antiserum 
corresponding to the type isolated from the sputum.
This method of typing by the Neufeld Reaction is also
8applicable to any body fluid containing pneumococci and was 
carried out in these cases associated with metastatic foci,
RESULTS OF TYPING.
Before detailing the results of typing, it must be 
borne in mind that many pneumococci, especially those previously 
designated Group IV. pneumococci, live as harmless saphrophytes 
in the throats of healthy individuals without causing any 
apparent upset.
As long ago as 1881, Sternberg and Pasteur observed 
that pneumococci which proved to be virulent to laboratory 
animals lived in the saliva of healthy persons. While Buerger, 
(1905) isolated pneumococci from the mouths of healthy persons in 
39 out of 78 cases. Hiss, Borden and Knapp, in a study of the 
pneumococcus in apparently normal throats went as far as to state 
that in New York in the winter time everybody harboured pneumococci 
at some time or other. Dochez and Avery (1915) stated that Types
I., II. and III. pneumococci were found associated with disease, 
whereas Group IV. pneumococci were principally saphrophytic in 
nature. Because of these findings, the importance of discovering 
Group IV. pneumococci in the sputum of patients suffering from 
pneumococcal pneumonia has been doubted, but Bullowa (1935) found 
a close correlation between the type of pneumococcus isolated 
from the sputum, blood culture and lung tissue in patients suf­
fering from pneumococcal pneumonia.
Because of the fact that pneurnococci found in the 
throats of healthy individuals may not necessarily be the 
causative organism in pneumonia, considerable care was exercised 
by me in the choice of the sputum specimen used for typing purposes. 
Saliva was discarded and where possible a rusty sputum was used, 
since the latter, containing lung juice from that organ in a
state of congestion, is more likely to contain the causative 
organism.
THE COMPARISON OP DIRECT TYPING WITH MOUSE TYPING.
The following table details the figures obtained by 
the two methods of typing.
Type Direct Mouse
I. 33) 39)
II. 78)124 85)143
III. 13) 19)
IV. 3 5
V. 2 3
VI. 2 3
VII. 6 8
VIII. 9 12
IX. 3 4
XI. - 1
XIII. 2 3
XIV. 1 1
XVIII. 2 2
XIX. 1 2
XX. 1 2
XXII. 2 2
XXIV. - 1
XXVII. 1 1
XXIX. 1 1
XXXIII. - 4
Total 160 200
In this series of 200 cases of pneumococcal pneumonia, 
direct typing failed to reveal the type of pneumococcus in 40 
cases. Of the organisms which failed to respond to direct typing, 
36 were successfully typed after mouse inoculation. Repeated 
attempts were made to classify the remaining four organisms which 
were proved to be pneumococci by bile solubility and inulin 
fermentation tests and since these occurred late in the series, 
and technical errors may be excluded, it may be assumed that these 
belong to the higher types which are known to exist but have not,
10
as yet, been serologically classified. Since it is known that 
there exists a relationship between Types II. and V., Types III. 
and VIII. and Types VII. and VIII. as shown by cross agglutina­
tion, particular attention was paid to these types, but in no 
instances was the Neufeld Reaction observed with the antiserum 
for any of the other types. This was no doubt due to the use of 
antisera prepared from rabbits which is more type specific.
In no cases did the result obtained from direct typing 
differ from that obtained by mouse inoculation, but the latter 
method, because of the abundance of organisms, was found to be 
much simpler and only took about half the time.
Prom the results, it can be seen that it is possible 
to identify the type of organism in 80 per cent of cases of 
pneumococcal pneumonia by the direct method. A certain percent­
age of the failures was probably due to the scantiness of the 
organisms in the sputum.
Only one case in the series revealed the presence of 
two types of pneumococci in the sputum - these being Type I. and
II. As this patient had a bacteraemia and since Type II. pneu­
mococci were isolated from the blood stream, it was accordingly 
classified as a Type II. infection.
RELIABILITY OF PNEUMOCOCCAL TYPING FROM SPUTUM.
While it is likely that in the presence of clinical 
consolidation of the lung that the type of organism Isolated 
from the sputum is responsible for the disease, can it be re­
garded as absolute proof, in view of the large number of people, 
who under normal conditions harbour pneumococci in their throats? 
Corroborative evidence as to the validity of sputum typing is 
available by three known methods: (1) Cultivation of the organ­
ism by transthoracic puncture of the consolidated area of the
11
lung; (2) By culture from the blood stream; (3) Isolation from 
metastatic foci. Lung puncture was not carried out in this series 
of cases, but Bullowa (1935), in a series of over 1,000, found 
that in 93 per cent of cases the type of organism isolated from 
the sputum corresponded with that isolated from the consolidated 
lung and from the blood stream. Sutliff and Finland (1933), 
comparing the type of organism isolated from both sputum and 
blood in 220 bacteraemic cases, found that the results tallied 
in 95 per cent.
In this present series, 44 bacteraemic cases were en­
countered and the type of pneumococcus isolated from the blood 
stream corresponded in 43 instances, and in the remaining one, 
two organisms were present in the sputum, one of which was present 
in the blood.
In addition to 44 bacteraemic cases, 10 patients were 
encountered with complications Including empyema, meningitis, 
pericarditis, abscesses and arthritis. No divergencies from 
the sputum typing were noted in typing the pathological fluid 
obtained from these lesions.
Little is known regarding the incidence of the higher 
types, formerly Group IV. pneumococci in cases of pneumococcal 
pneumonia in this part of the country, consequently no figures 
are available for the purposes of comparison.
This series of 200 patients represents a study of cases 
of typed pneumococcal pneumonia admitted to Knightswood Hospital 
during a period of 15 months, and for the sake of comparison I 
have utilised the figures presented by Bullowa as representing 
an investigation by a series of workers.
12
Type
No.of Cases Percentage
Bullowa Author Bullowa Author
I. 253 39 25.3 19.5
II. 79 85 7.9 42.5
III. 115 19 11.5 9.5
IV. 65 5 6.5 2.5
V. 60 3 6.5 1.5
VI. 29 3 2.9 1.5
VII. 69 8 6.9 4.0
VIII. 98 12 9.8 6.0
IX. 25 4 2.5 2.0
X. 8 - 0.8 -
XI. 6 1 0.6
to•o
XII. 14 - 1.4 -
XIII. 8 3 0.8 1.5
XIV. 45 1 4.5 0.5
XV. 1 - 0.1 -
XVI. 4 - 0.4 -
XVII. 8 - 0.8 -
XVIII. 24 2 2.4 1.0
XIX. 16 2 1.6 1.0
XX. 11 2 1.1 1.0
XXI. 13 - 1.3 -
XXII. 16 - 1.6 -
XXIII. 3 - 0.3 -
XXIV. 3 1 0.3 0.5
XXV. 2 - 0.2 -
XXVII. 2 - 0.2 -
XXVIII. 9 - 0.9 -
XXIX. 5 1 0.5 0.5
XXX. 2 - 0.2 -
XXXI. 2 - 0.2 -
XXXII. 4 - 0.4 -
XXXIII. - 4 - 2.0
1,000 200 100 100
It will be observed that the percentage distribution 
of the various types of causative organism varies widely in the 
two series of cases. Although the total number of cases under 
review only total one fifth of Bullowa’s series, the number of 
Type II. cases is higher in the smaller series. In America, 
as illustrated by the figures above, Type I. is the most 
prevalent, then Type III. and Type II., whereas in the above 
series Type II. by far accounted for the greatest number of 
cases, then Type I. and Type III. This latter fact is in keeping
13
with previous work done on pneumoceoccal typing in this hospital,
and also with that of Cruikshank (1933) working in Glasgow.
It may he seen from the results that in 71.5 per cent 
of the cases, in the present series under review, the causative 
organism belonged to Types I., II. and III. This would suggest 
that in an epidemic when pneumonia patients are admitted in large 
numbers and time is limied, that the sputum should be tested 
firstly against Types I., II. and III. antisera.
The higher types of pneumococci in order of frequency 
of occurrence was:-
Bullowa, VIII. VII. IV. V. XIV. VI. IX.
Author, VIII. VII. IV. IX. V. VI.
Although the series is small, the similarity in the
ranking of the higher types of the pneumococcus is noteworthy.
It is known that the severity of pneumococcal pneumonia 
varies with the type of infecting organsim. Since the series of 
200 cases is small and various methods of treatment have been 
employed, it is impossible to draw any conclusions regarding the 
mortality rate as regards type of infecting pneumococcus solely. 
Now that all patients suffering from pneumococcal pneumonia are 
being treated with either serum or Sulphapyridine, it will be 
possible, if the series is sufficiently large, to assess the 
virulence of the higher types of pneumococcus and estimate the 
average death rate In pneumococcal pneumonia due to the various 
types of organism.
Conclusions;
1. The pneumococcus isolated from the sputum of patients
suffering from pneumococcal pneumonia is the causative 
organism of the disease, as confirmed by blood culture 
and isolation of the organism from metastatic food.
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2. By direct sputum typing, it was possible to type the
pneumococcus in 80 per cent of all cases.
3. In this series, mouse typing gave the result in 20
per cent of cases in which direct typing failed,and 
confirmed direct typing in 100 per cent.
4. Only 2 per cent of cases failed to be serologically
typed into the 30 known types.
5. The order of frequency of occurrence of pneumococci
isolated from patients suffering from pneumococcal 
pneumonia in this series of cases is Type II., I.,
III., VIII., VII., IV., IX., V. and VI.
6. Comparable data from U.S.A. indicate gross differences
in the relative frequency of the several types, 
particularly Type II. It is possible, therefore, 
that differences of the same order may emerge from 
investigations of the geographical variations within 
this country. This is of obvious importance in view 
of the wide variations in fatality attributable to 
the type of infecting pneumococcus.
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BLOOD PICTURE IN PNEUMONIA•
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BLOOD PICTURE IN PNEUMONIA.
A leucocytosis signifies an effective response to any 
increased demand for leucocytes, and is exemplified in most in­
fections due to pathogenic bacteria. The degree and kind of 
leucocytic response depends on whether the infection is acute or 
chronic, and also to large extent on the causative organism.
The pneumococcus belongs to that group of pathogenic organisms, 
infection with which tends to induce a well marked leucocytosis, 
the increase being most marked in the polymorphonuclear leucocytes, 
while the circulating lymphocytes and monocytes are reduced and 
eosonophils are usually absent. The degree of leucocytosis in 
pneumococcal pneumonia varies with the type of infecting organism 
has been shown by Fleming (1936) who pointed out that during the 
initial stages of the illness, a leucocyte count of more than
20.000 cells per cmm. is the usual finding in Type I. and Group
IV. infections, whereas patients suffering from Type II. and 
Type III. infections usually have an initial count of less than
20.000 cells per cmm.
An increase in the total circulating leucocytes above
10.000 cells per cmm. Is known as a leucocytosis, and while this 
is the rule in patients suffering from pneumonia, even although 
the infection is mild, patients with a severe infection may show 
no increase in leucocytes and even a diminution. A diminution 
below 5,000 cells per cmm. is known as a leucopenia, and is 
probably due in most instances to the overwhelming effect of the 
toxin on both the circulating leucocytes and the bone marrow, 
occurring before the body is able to respond to the infection.
THE PROGNOSTIC SIGNIFICANCE OF THE LEUCOCYTE COUNT.
Studies of the prognostic significance of the leucocyte
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count in patients suffering from pneumococcal pneumonia have 
been frequently recorded with conflicting results, e.g. the 
Rockefeller workers (1917), in a series of 463 untyped cases, 
showed that the mortality rate was inversely proportional to the 
degree of leucocytic response. These findings were confirmed by 
Raegli (1923) and Meyer (1931) who found that the death rate, in 
patients suffering from pneumonia, was highest where the leucocyte 
response was poor, but they also showed that deaths did occur in 
spite of the existence of a well marked leucocytosis. In con­
trast to the findings of these workers, Bullowa (1927), Von Wyss 
(1921) and their associates, found no relationship between the 
degree of leucocytosis and the outcome of the illness, while 
Middleton and Gibson (1930) showed that in most cases, a well 
marked leucocytosis was usually a favourable sign. Christie 
(1933) reported the case of a male patient, aged 30 years, who 
was admitted to hospital on the third day of illness suffering 
from Type II. pneumonia accompanied by a bacteraemia. The patient 
died on the 6th. day of illness and at that time the blood culture 
was negative and the leucocyte count 42,000 cells per cmm. In 
other words, the body had successfully combatted the bacteraemia, 
the leucocyte count pointed to recovery taking place, yet in spite 
of these facts, the illness terminated fatally. Fleming (1936) 
in his study of the leucocyte count in typed lobar pneumonia, 
concluded that while a leucocyte count of over 15,000 cells per 
cmm. in the first three days of illness was a good prognostic 
sign, it was difficult to prognosticate from that one finding 
alone. He showed that the degree of leucocytosis in patients 
suffering from pneumonia varied with the type of infecting 
pneumococcus. A lower leucocyte count being the normal accom­
paniment of Type II. and Type III. infections compared with Type 
I. and Group IV. and that to be of any real value in prognosis
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it was necessary to repeat the count at daily intervals and to 
take into account the age of the patient and the duration of the 
illness.
During this investigation, routine leucocyte counts 
were performed on 67 cases of typed pneumococcal pneumonia, on 
admission to hospital, and in 20 of these the count was repeated 
at intervals of one or two days with a view to assessing the 
probable outcome of the illness. It should be stated that of 
the 67 patients studied, 28 were treated with type specific 
antipneumococcal serum. Of the 67 cases examined, 17 died and 
50 recovered and the leucocyte counts along with the type dis­
tribution of the infecting organism are detailed below.
LEUCOCYTE COUNT ON ADMISSION TO HOSPITAL.
Total
Count
Number Recoveries Number Deaths
of
Cases
Type of
Cases
Type
I. II. III. Group IV. I. II. III. Group IV.
Below
10,000 6 2 3 1 7 _ 5 1 1
10-15,000 8 3 1 - 4 4 - 2 - 2
15-20,000 13 5 6 - 2 2 - 2 - -
20-30,000 10 5 4 - 2 4 1 3 - -
30,000
upwards 13 8 3 - 2 - - - - -
50 23 17 - 11 17 1 12 1 3
Observations from Table I. show that 11 of the 17 
patients who died, or 65 per cent, had an initial leucocyte 
count of under 15,000 cells per cmm., whereas 36 of the 50 
patients who recovered, or 72 per cent, had an initial count of 
over 15,000 cells per cmm. The average figure for the non fatal
CHAftT I
19
cases was 21,000 cells per cmm. as compared with 13,000 cells 
per cmm. for the fatal cases. The highest initial counts were 
observed in Type I. infections. Thus, while a good leucocyte 
response may be regarded as a favourable omen, it by no means 
guarantees that recovery will take place. A leucopenia, on the 
other hand, must be regarded as a sign of grave prognostic sig­
nificance, but it does not necessarily mean that the illness 
will have a fatal termination. This latter finding may be il­
lustrated by the following case encountered during the investi­
gation.
A male patient, 48 years of age, was admitted to 
hospital on 3rd. day of illness, suffering from a Type I. 
pneumonia, involving the entire left lung. He had a positive 
blood culture and a leucocyte count of 6,500 cells per cmm. In 
addition to the usual nursing, he was given 130,000 units of Type
I. antipneumococcal serum. On the following day the blood culture 
was negative and the leucocyte count fell to 5,000; 3,200; 2,400 
cells per cmm. on successive days and then rose to 3,500; 8,000;
10,000 cells per cmm. on subsequent days and the patient recovered.
In the small number of patients on whom daily blood 
counts were performed, it was found that great variations occurred. 
Of the patients who died, the final count before death varied 
between 3,200 and 25,000 cells per cmm., and a rising leucocyte 
count was occasionally encountered in the fatal cases, which tended 
to be misleading. Inspection of the levels of the leucocyte count 
in the two series of fatal and non fatal cases, together with 
their trend during the course of the illness, clearly indicates 
the consistently higher level in the non fatal cases as well as 
the more rapid return to normal levels. (See Chart I.).
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THE PROGNOSTIC SIGNIFICANCE OF THE 
DIFFERENTIAL LEUCOCYTE COUNT!
It was pointed out by Arneth (1904) that in diseases
accompanied by a toxaemia, there occurred a change in the
character of the nuclei of the circulating neutrophil polymor-
phonuclears which, instead of being segmented, took on a form
of a band or kidney shape. He evolved the Arneth count in which
the polymorphonuclears were divided into five groups, according
to the number of segments in the nuclei. These five groups he
further sub-divided according to the shape of the lobes. The
changes which took place in infective disease, i.e. an increase
of the mono-lobed cells at the expense of the bi-lobed and tri-
lobed, etc., he described as a Mshift to the left”, occurring
independently of leucocytosis or leucopenia. The Arneth count,
however, because of its complexity, has not been employed much
in practice, but certain modifications have been described.
Cooke and Ponder (1927), using a modification of the
Arneth count, in which the cells were classified according to the
number of filaments joining the lobes of the nuclei, showed that
the differential count was of definite value in the diagnosis,
prognosis, and treatment of infective diseases, the degree of
"shift to the left” varying with the severity of the Infection.
A simpler and more practicable method of interpreting
the leucocyte count was described by Schilling (1929), in which
the total count and differential count were grouped together in
the form of a haemogram. He divided the neutrophil leucocytes
into four groups, according to the character and shape of their
nuclei, as follows
I. Myelocytes (M) which have a rounded or slightly 
indented nucleus.
II. Juvenile polymorphonuclears (J) which have a kidney 
shaped nucleus.
21
III. Stab Cells (St.) which have their nuclei in the form 
of a band which may be bent on itself.
IV. Segmented polymorphonuclears (S) which are cells 
having two or more nuclei.
Thus, Schilling did not sub-divide the mature polymor­
phonuclears, but classed them all as one.
According to Schilling, the normal intermediate stage 
in development from a myelocyte to the segmented polymorphonuclear 
is the juvenile form but, in infective conditions, this normal 
maturation is interfered with, and the juvenile form takes on the 
form of a stab cell with its characteristic shape of nucleus. 
Whether this is the case or not, it may be assumed that the 
myelocyte, juvenile form and stab cell are all primitive polymor­
phonuclears and have not the same phagocytic powers as the seg­
mented, fully formed polymorphonuclear.
The normal figures for Schilling’s haemogram are as
follows:-
Neutrophils
Total
Count
Baso­
phils
(B)
Eosino­
phils
(E)
Myelo­
cytes
(M)
Juven­
ile
Forms
(J)
Stab
Cells
(St.)
Seg­
mented
Polymor-
phonu-
cU V a
Lympho­
cytes
(L)
Mono­
cytes
(Mon)
5-8,000 0.1 2.4 - 0.1 3.5 51.67 21.35 4.8
In any infective condition, Schilling describes two 
types of reaction.
(1) A regenerative reaction, which is usually seen in acute
infections, and is characterised by a raised leucocyte 
count and the appearance of juvenile forms and myelocytes 
in the blood. This is due to an active regeneration on 
the part of the bone marrow in response to the infection.
(2) A degenerative reaction, characteristic of typhoid fever,
tuberculosis, and certain protozoal infections. The
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overwhelming effect of the toxin inhibits the action 
of the bone marrow, thereby causing a leucopenia and 
a high percentage of stab cells in the blood.
The reaction to most infections is commonly a mixed 
one, i.e. degeneration with regeneration, so that there is a 
resultant increase of all the younger forms of neutrophils in 
the blood, and the increase depends on the severity of the in­
fection.
Schilling describes the blood changes in an acute in­
fection terminating with recovery as follows
(1) Leucocytosis with a ’’shift to the left", the degree of
"shift” varying with the severity of the infection. 
Absence of eosinophils and reduction of lymphocytes 
and monocytes.
(2) A progressive decrease in the "shift to the left" on
successive days.
(3) A return of eosinophils and an Increase in the lymphocytes
and monocytes.
The practical application of the haemogram is illus­
trated by Schilling, who uses this method of study in all infec­
tions. In his book (The Blood Picture and its Clinical 
Significance, 1929) only two cases of pneumonia are cited by 
him, and these show the importance of the haemogram as a factor 
in attempting to forecast the outcome of the disease, namely:-
CASE I.
Day of Illness
Total
Count B. E. M. J. St. S. . L.’ Mon.
, t
6th. 12,300 - - - 4 32 51.5 11.5 1
8 th. 8,200 - - - 3 22 63.0 10.5 1.6
The blood findings on the 6th. day of illness showed 
that 36 per cent of the cells were embryonic polymorphonuclears, 
whereas 51.5 per cent were fully formed polymorphonuclears, i.e.
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there was a "shift to the left” of a moderate degree occurring 
fairly late on in the illness. The haemogram, two days later, 
showed a considerable decrease in the "shift” consistent with a 
favourable response to the infection and recovery ensued. It 
will be noted that the total neutrophil polymorphonuclear count 
on these two days showed no great variation, viz. 87.5 per cent 
compared with 88 per cent.
CASE II.
Day of Illness
Total
Count
t .
B. E. M. J. St. S. L. Mon.
2nd. 10,000 - - - 20 17 41 13 9
3rd. 8,600 - - 1 30 18 35 11 5
In contrast to Case I., the above case showed a con­
siderable degree of "shift to the left", the embryonic cells 
totalling 37 per cent and the fully formed polymorphonuclears 
41 per cent. These findings were more significant since the 
patient had only been ill for two days. On the following day 
the haemogram showed a greater increase in the initial "shift to 
the left" and the illness terminated fatally. Again there was 
no significant difference in the total neutrophil polymorphonuclear 
count on these two days, the figures being 78 per cent and 84 per 
cent.
In this investigation, in addition to a total leucocyte 
count, a Schilling count was performed, on admission to hospital, 
on 67 cases of typed pneumococcal pneumonia. Pressure of work, 
however, prevented the collection of a sufficient series of 
duplicate observations on these patients at particular Intervals, 
but in 20 instances the count was repeated daily or at intervals 
of two days. Particular attention was paid to what Schilling
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describes as the Central Quaternary Figure which includes the 
four types of granulocytes, viz: Myelocytes, Juvenile Polymor­
phonuclears, Stab Cells and Segmented Polymorphonuclears, which, 
in the normal differential count comprise the neutrophil polymor­
phonuclears .
Tables detailing the blood findings in 12 patients, 
who died within 24 hours of admission to hospital, are discussed 
and in addition daily haemograms with temperature charts and 
clinical findings are submitted in four cases as illustrating 
the prognostic significance and importance of the Schilling count.
The blood films from these patients were prepared in 
the usual manner, either on glass slides or coverglasses and were 
treated as follows:-
1. Stain with Jenner's Stain for two minutes.
2. Wash in running water for one minute.
3. Stain with Giemsa's Stain, in a dilution of 1 drop
to 1 c.c. of water, for twenty minutes.
4. Wash with water.
5. Allow to dry.
The blood films were examined under an oil immersion 
lens and as advocated by Schilling, an average of 200-300 cells 
were counted and the cells classified according to the Schilling 
Haemogram.
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TABLE I.
ANALYSIS OP 12 CASES WHICH PROVED FATAL WITHIN 
22 HOURS QP ADMISSION TO HOSPITAL.
Age
Day
of
Admission Type
BlooH 
Cul­
ture . Total B. E.
Neutrophils
L. Mon.M. J. St.. S.
1. 38 3rd. II. .. 12,000 1 5 47 41 4 2
2. 37 5th. II. + 8,000 - - 12 34 22 10 21 0
3. 64 6 th. II. + 3,200 - - 3 10 49 28 4 6
4. 52 3rd. II. - 5,500 - - 5 14 58 16 6 1
5. 62 6th. III. + 6,000 - - 10 15 32 40 2 1
6. 64 5th. III. +• 4,600 - - 5 20 45 22 8 0
7. 43 7 th. III. + 13,200 - - 3 10 49 28 4 6
8. 45 6th. III. 6,800 - - 10 24 47 7 10 2
9. 61 3rd. IV. - 13,000 - - 15 6 44 37.5 11 2
10. 57 5th. V. + 7,200 - - 1 16 56 25 2 0
11. 57 4th. VI. - 7,000 - - - 2 43 46 6 3
12. 50 5 th. XI. 4 12,000 - - 1 2 43 40 8 6
Table I. details, in addition to the admission haemogram, 
the age of the patient, type of infecting pneumococcus, presence 
or absence of bacteraemia, and the duration of illness, for twelve 
patients, who died within 24 hours of admission to hospital.
It will be observed that nine of the twelve patients 
had a total leucocyte count of 8,000 cells per cmm. or under, 
while the remaining three patients had counts of 12,000; 12,000 
and 13,000 cells per cmm. respectively, i.e. the total leucocyte 
count yielded important information from the point of view of 
prognosis in 75 per cent of the cases, but the Schilling Count 
in every case showed a marked nshift to the left", indicating a 
grave prognosis. The average values for the Haemogram in the 
twelve cases were:
Total Count B. E. M. J. St. S. L. Mon.
8,200 - - 4 13 45 28.5 7 2.5
The average total percentage of primitive neutrophils
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in the blood was 62, while the percentage of segmented polymor­
phonuclears was as low as 28.5.
Before further stressing the importance of the Schilling 
Count as a prognostic factor, I would like to point out, since 
the wshift to the left” is an indication of the toxaemia, the 
duration of the illness should be taken into account as a 
moderate degree of "shift to the left" will be of more signifi­
cance in a patient who has been ill for a day or two, compared 
with a patient who has been ill for several days. Similarly, 
every patient who dies from pneumonia may not necessarily show 
a marked "shift to the left", as he may die from causes other than 
a pneumococcal toxaemia, for example, acute heart failure, pul­
monary embolism, renal insufficiency.
ANALYSIS OF FOUR INDIVIDUAL CASES.
The following cases, however, illustrate how important 
information can be obtained from the Schilling Count.
Case I. J.T. Case II. J.M.
Age
Day of Illness
Involvement
Type
Blood Culture
Total White Count 
Temperature 
Pulse Rate 
Respiration Rate
15 ye ar s .
3rd.
R. 2 3 
II
Positive 4 colonies 
per c.c. blood. 
13,000 cells per cmm. 
103 degrees.
140
40
15 years.
4 th.
R. 2 
II
Negative.
8,000 cells per cmm. 
103 degrees.
140
36
Both of these patients were young boys and the results 
of investigation, as seen from the above table, showed that, 
clinically, they appeared very similar. The chief differences 
were that Case I. had a bacteraemia but the blood was not invaded 
to a very marked degree, whereas Case II. had a poorer leucocyte 
response. The course of the illness may be seen on the accompanying
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temperature charts. Case I. died on the 10th. day of illness, 
while Case II. had a crisis on the 7th. day of illness. Both 
patients were treated with type specific antipneumococcal serum. 
The respective haemograms on admission were:
Total Count B. E. M. J. St. S. L. Mon.
Case I. J.T. 13,000 . . 1 10 44 36 6 2
Case II. J.M. 8,000 — * "" * 12 74 11 2
The discrepancy in the blood findings shows the marked 
difference in severity of the illness in the two cases, the 
"shift to the left1 being greater in Case I. than Case II. In 
the latter case, there was an immediate response to serum treat­
ment .
Daily haemograms for the two cases are detailed below.
J.T. CASE I.
Day of 
Illness
Total
Count B. i E- M. J. St. S. L. Mon.
3rd. 13,000 1 10 44 36 4 2
4 th. 13,000 - - - 13 39 40 8 -
5th. 5,000 - - 1 10 48 36 4 1
6th. 4,000 - - 2 9 50 34 4 1
7th. 8,000 - - 3 11 54 28 4 1
8th. 7,000 - - 4 12 51 26 6 1
9 th. 6,000 - - 10 18 54 18 8 2
10th. Died. 
1
J.M. CASE II.
Day of Total
Illness Count B •. E. M. J. St. S. L. Mon.
4 th. 8,500 _ . ^ 12 74 11 3
5th. 10,000 - 1 - - 10 69 16 4
7th. 7,000 - 3 — - 5 67 20 5
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In Case I. the daily examination of the blood revealed 
a progressive "shift to the left" and as can be seen from the 
accompanying chart, a more extensive invasion of the blood stream 
by the pneumococcus. The patientfs general condition gradually 
deteriorated, and there was a spread of the pneumonic process to 
the neighbouring lung tissue. Case II., on the other hand, showed 
an immediate response to the serum treatment as seen from the 
immediate fall in temperature, pulse and respiration rates. From 
the beginning, the illness as determined by an examination of the 
blood, was not of a serious nature.
During this investigation several cases were encountered 
which clinically proved to be misleading, and in which the blood 
picture yielded much valuable information. The following are 
examples of such cases.
Case III. J.M. Male, aged 26 years, admitted to hospital 
on 5th. day of illness, suffering from a Type XVIII. pneumococcal 
pneumonia involving the lower lobe of the left lung. He had a 
positive blood culture (broth only) and a total white count of
12,000 cells per cmm. The initial temperature was 103 degrees, 
pulse rate 104, and respiration rate 36.
This patient was delirious on admission to hospital and 
was critically ill for several days. As can be seen from the ac­
companying chart, his temperature remained high for six days and 
fell dramatically on the 12th. day of illness. He had a mild 
bacteraemia on admission, but on subsequent examination, the 
blood was found to be sterile. He was a typical example of many 
pneumonia patients whose lives are often despaired of and who, on 
reaching the crisis, make a dramatic recovery. Examination of 
his blood, however, on admission to hospital and on subsequent 
days, showed that the patient was combatting the infection very 
well and this is illustrated in the following haemogram.
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J.M. CASE III.
Day of 
Illness
Total white 
Count B. E. M. J. St. S. L. Mon.
5th. 12,000 3 22 62 13
7th. 12,000 - - - 3 18 65 10 4
9 th. 14,000 - - - 1 16 69 12 2
10 th. 10,000 - - - 2 14 69 12 2
12th. 10,000 — 1 — 1 10 73 11 2
In spit© of the clinical severity of the case, the 
blood picture only showed a moderate degree of Mshift to the 
left” on admission, and the 1 shift” decreased on the ensuing days.
Case IV. J.H. Male, aged 58 years, admitted to hospital on 
2nd. day of illness with a Type II. pneumococcal pneumonia, in­
volving the middle lobe of the right lung. Blood culture was 
negative on admission and the total white count was 9,000 cells 
per cmm. The initial temperature was 100 degrees, and pulse rate 
104, and respiration rate 32. This patient was classed as 
moderately ill, and since he was in the early stages of the ill­
ness, it was decided to treat him with Type II. antipneumococcal 
serum. On the introduction of one drop of serum into his vein, 
however, he took a shivering turn and complained of a choking 
sensation in his throat and collapsed. It was decided, since he 
did not seem very ill, to abandon the giving of serum. On the 
following day he looked much better and as the accompanying chart 
shows, the temperature, pulse and respiration rates were all on a 
lower level. On subsequent days the temperature began to rise, 
and while the pulse and respiration rates were not very rapid, 
the infective process spread to involve the entire right lung, 
the organism invaded the blood stream and the patient died two 
days later.
This was an example of several cases which were en­
countered, namely, death occurring in a patient who, on admission
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to hospital, as judged hy clinical appearances and extent of 
involvement of lung tissue, did not look acutely ill.
The initial haemogram, however, yielded the following
results:
J.H. CASE IV.
Day of 
Illness Total Count B. E. M. J. St. S. L. Mon.
2nd. 9,000 - - 1 10 37 47 2.5 2.5
The blood picture showed a considerable 1 shift to the
left” out of all proportion to the clinical findings and day of
illness - the embryonic white cells totalling about 50 per cent.
The blood findings for the course of the illness were
as follows:
Day of 
Illness
Total White 
Count i B* , E. M. J. St. S. L. M.
2nd. 9,000 1 10 37 47 2.5 2.5
3rd. 10,000 - - - 10 41 34 6 7
4 th. 16,000 - • - 10 49 30 4 5
5th. 15,000 - - 3 12 47 26 7 4
6th. Died.
A progressive Mshift to the left" in spite of a rise 
in the total white count, accompanied the gradual deterioration 
in the patient’s condition and the spread of the pneumonia to the 
other lobes of the right lung. Because of the poor Initial blood 
findings, the prognosis in this case was proclaimed serious from 
the pnset, a finding which was proved to be correct by the ultimate 
result. Daily blood cultures were performed, but the blood stream 
was not involved until the day before death occurred.
From the foregoing cases, it can be seen that the blood 
picture may often give some guidance as to the gravity or levity 
of the illness, especially in these cases which clinically and 
bacteriologically may be misleading.
DETAILS OP ADMISSION HAEMOGRAMS IN 67 PATIENTS 
SUFFERING PROM PNEUMOCOCCAL PNEUMONIA.
Of the 67 patients investigated, 17 died and the average
figures for the haemogram on admission to hospital were:
TABLE II.
Total Count . B. E. M. J. St. S. L. Mon.
13,000 - - 2 7 40 43 6 2
In contrast, the figures for the 50 patients who re­
covered were:
TABLE III.
Total Count B. E. M. J. St. S. L. Mon.
21,000 - - 0.5 1 20 66 6.8 4
The above data was based on examination of the patients’ 
blood on admission to hospital and the wide variations, 49 per 
cent of embryonic cells compared with21.5 per cent, in the two 
groups of cases can be seen. This difference is highly signifi­
cant. It will be noted that the total neutrophil polymorphonuclears
in the two series show figures of 92 per cent for the fatal and
87.5 per cent for the non fatal cases - figures from which no con­
clusion can be drawn.
COMPARISON BETWEEN HAEMOGRAM ON ADMISSION TO HOSPITAL
AND AFTER 48 HbURSl
While the initial blood findings are of considerable
value, an even better guide as to the progress of a case is the
comparison of the initial blood findings with those at a later 
date.
In support of this statement, the following table de­
tailing the average values for the haemogram two days after ad­
mission to hospital are submitted for 10 patients who died^and
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10 who recovered. Seven on the seventeen deaths occurred within
48 hours of admission to hospital.
TABLE IV. 
HAEMOGRAM AFTER 48 HOURS.
Number 
of Cases
Total
Count B. E. M. J. St. S. L. Mon.
Deaths 10 14,000 mm 2.5 16 45 31 3.5 2.0
Recoveries 10 17,000 - 0.5 - 0.5 13.5 75.5 6.0 4.0
Compared with Tables II. and III., the haemograms after 
48 hours show a progressive "shift to the left" in the fatal cases 
and a "shift to the right" in the non fatal cases.
In view of the fact that Tables II. and III. are based 
on the findings for the entire series and the above Table IV. Is 
limited to 20 patients on whom it was possible for me to repeat 
the reading, I felt it advisable to strengthen the conclusion 
arrived at, by presenting the initial results based only on the 
same patients on whom duplicate observations were made.
TABLE V .
AVERAGE HAEMOGRAM OF 10 FATAL CASES.
Total
Count B. E. M. J. St. S. L. Mon.
Admission 12,500 • - 2.1 9 42 39 5.4 2.6
After 
48 Hours 14,000 - - 2.5 16 45 31 3.5 2.0
TABLE VI.
AVERAGE HAEMOGRAM OF 10 NON-FATAL CASES.
Total
Count B. E. M. J. St. S. L. Mon.
Admission 27,000 - - 0.4 1.2 19. 68.4 6.2 3.8
After 
48 Hours 17,000 - 0.5 - 0.5 13.5 75.5 6.0 4.0
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The result obtained by examining the foregoing Tables
V. and VI., confirms the above findings, namely, that there oc­
curred a progressive ”shift to the left” in the fatal cases and
a ’’shift to the right” in the non fatal cases.
Conclusions.
1. The initial total leucocyte count is of value in
prognosis in pneumococcal pneumonia.
2. Examination of the blood by a differential count as
advocated by Schilling in patients suffering from 
pneumococcal pneumonia, shows "a shift to the left”.
3. The degree of ’’shift to the left” is an indication
of the degree of toxaemia and severity of the 
infection.
4. The comparison between the initial differential count
and a count done two days later, gives definite
information regarding the progress of the infection 
and probable outcome.
5. The differential count is of especial value in cases
which clinically and bacteriologically may be mis­
leading.
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EFFECT OF SULPHAPYRIDINE ON FATALITY RATE 
FROM PNEUMOCOCCAL PNEUMONIA.
The ever increasing strides by which our knowledge of 
the pneumococcus has progressed during the past years has led 
to corresponding advances in the treatment of pneumonia in man.
The two main offensives against this disease have been launched 
through the agencies of antisera and certain drugs. The 
Klemperers (1891) were the first workers to use antisera for 
curative purposes and their failure to obtain satisfactory re­
sults is attributable to the existence of different types of 
pneumococci, which were at that time unknown. The subdivision 
of the pneumococcus into its various types heralded the insti­
tution of treatment with type specific antisera, and while the 
results were at first disappointing, due to difficulties in 
identifying the type of infecting organism and the low potency 
of the available antisera, refined type specific antipneumococcal 
sera have produced encouraging results in the United States of 
America which have not, however, been confirmed in this country.
Many chemical substances have been employed in the 
treatment of pneumonia, and while hopeful results were obtained 
by Morgenroth and Levy (1911) using Optoquine in experimental 
infection in mice, these have not been confirmed in the treatment 
of pneumonia in man, and the employment of this drug may have 
serious toxic complications.
The advent of the Sulphonamide group of drugs opened 
up a new channel in the treatment of bacterial infections, and 
while the earlier drugs, for example, Prontosil, were used with 
outstanding success in streptococcal infections, the results in 
the treatment of pneumonia, with the exception of an occasional 
success reported by Heintzelman, Hadley and Mellon (1937) and Brown,
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Bannick and Habein (1937) were disappointing. The discovery by 
Whitby (1938) that 2 - (p - Aminobenzene Sulphonamido) Pyridine 
now generally known as Sulphapyridine was chemotherapeutically 
active against certain types of pneumococci, and the encouraging 
results of a clinical trial of the new drug by Evans and Gaisford 
(1938) confirming Whitby’s experimental work in mice, indicated 
that a new effective treatment for pneumonia had been discovered. 
Since then, various workers in this and other countries have re­
ported great reductions in the fatality rate in series of cases 
treated with Sulphapyridine. In a summary dealing with the 
treatment of pneumonia with Sulphapyridine, Marriott (1939) 
showed that, up to the time of writing, 1991 published cases had 
been treated, with a death rate of 5.5 per cent.
During the months of September, 1938, and March, 1939,
I have collected data in respect of a series of cases treated 
with Sulphapyridine with a view to evaluating its effect on 
fatality from pneumococcal pneumonia, and in all 90 patients, 
so treated, were investigated. In any such attempt, comparison 
should be made between the results in a treated series and those 
found in a properly constituted control group, in other words, 
a group which resembles the Sulphapyridine treated series in 
every influential aspect apart from the drug treatment. Such 
a control series can be obtained theoretically by generally ac­
cepted methods of admitting to the two series, alternate cases. 
This was the method used by Evans and Gaisford (1938) and their 
results were so striking as to warrant the administration of the 
drug to every patient admitted to hospital. Consequently, in 
this investigation, two separate series have been compared.
Before commencing the comparison, however, it is firstly desirable 
to discuss the variable factors which may influence the outcome 
of an attack of pneumonia. These factors, some of which are
already known to have a bearing on the probable termination, 
are discussed below, and their significance tested statistically.
1• Age of Patient.
It is generally recognised that the severity of 
pneumococcal pneumonia varies with the age of the patient, and 
that in elderly patients the prognosis is more serious. There­
fore, in assessing the value of any new treatment, the age 
grouping of the patients must be taken into account.
^• Days ill when admitted to Hospital.
In hospital practice, the prognosis is usually con­
sidered worse in patients who are admitted to hospital late in 
the illness, as the facilities for nursing in hospital are better, 
and nursing, apart from any specific treatment, is a very Important 
factor in the treatment of pneumonia.
It is often difficult to state exactly how long the 
patient has been suffering from pneumonia prior to admission to 
hospital, as the common cold is a frequent precursor to an attack 
of pneumonia. The best guide is the state of the consolidation 
of the lungs or the date of the initial rigor which so character­
istically signifies the onset of pneumonia, and these have been 
my criteria in determining this factor. It might be argued that 
the longer a patient suffering from pneumonia lives, the nearer 
he will be to a natural crisis. While this is so, the former 
statement that his chances of recovery are jeopardised by delay 
in transference to hospital would seem more than to counterbalance 
the latter factor. Analysis of the series under consideration, 
however, reveals that the days ill before admission to hospital 
had no bearing on the ultimate result.
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3. Type of Infecting Organism*
TABLE I.
TYPE OF INFECTING ORGANISMS IN PNEUMOCOCCAL PNEUMONIA.
Period
of
Investi­
gation
Numbers and 
Mortality Rates TotalType
I.
Type
II.
Type
III.
Group
IV.
1933
Knightswood Hospital 
Percentage of Total 
Deaths
Case Mortality per Cent
47
27.3
6
12.7
71
41.2
15
21.1
10
5.8
6
60
44
25.5 
6
13.5
172
33
19.1
1934
Knightswood Hospital 
Percentage of Total 
Deaths
Case Mortality per Cent
36
29.2
2
5.5
41
33.3
10
24.3
5
4.1
5
100
41
33.3
4
9.7
123
21
17.07
1935
Knightswood Hospital 
Percentage of Total 
Deaths
Case Mortality per Cent
28
23.9
1
3.5
44
37.6
8
18.1
7
5.9
2
28.5
38
32.4
2
5.2
117
13
11.1
1936
Knightswood Hospital 
Percentage of Total 
Deaths
Case Mortality per Cent
20
29.9
2
10
30
44.8
10
33.3
4
5.9
1
25
13
19.4
4
30.8
67
17
25.4
1937
Knightswood Hospital 
Percentage of Total 
Deaths
Case Mortality per Cent
36
26.08
3
8.3
52
37.6
32
61.5
20
14.4
17
85
30
21.7
12
40
138
64
46.3
1938
Knightswood Hospital 
Percentage of Total 
Deaths
Case Mortality per Cent
32
23.7
1
3.1
58
42.9
16
27.5
10
7.4
6
60
35
25.9
8
22.8
135
31
22.9
Total Cases 
Percentage of Total 
Total Deaths 
Case Mortality per Cent
199
26.4
15
7.5
296
39.3
91
30.7
56
7.4
37
66.07
201
26.7
36
17.9
752
179
23.8
The accompanying Table I. details the mortality rate 
from pneumococcal pneumonia during the past six years in 
Knightswood Hospital, arranged according to the type of infecting 
pneumococcus. The differences in fatality rate from the various 
types can be readily observed, confirming the findings of 
Cruickshank (1933), and while Type III. pneumonia has proved 
to be the most virulent, Type II., because of its most frequent
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occurrence, accounted for the greatest number of deaths. The 
type incidence, however, as well as the type fatality, do vary 
from place to place as can be seen in Bullowafs series discussed 
in Chapter I., which shows a greater incidence of Type III. in­
fections, whereas Type II. are relatively infrequent. Variations 
may also occur in different parts of this country as illustrated 
by Gaisford who, at the British Medical Association meeting, 
Aberdeen, 1939, produced a series of 188 typed pneumonias of 
which 94 (50$) were due to Type I. pneumococcus. Cruickshank 
(1933), in addition, has pointed out that not only does the in­
cidence of type of pneumococcus vary from place to place, but 
also from year to year. Hence, it is essential in attempting to 
assess the efficiency of a new treatment for pneumonia, to detail 
the types of pneumococci responsible for the infection.
4. Variations in Annual Severity.
It is not sufficient merely to assume that because one 
cannot recognise clinically definite annual variations in the 
severity of cases admitted to hospital that, in fact, such vari­
ations do not exist. The experience of this Hospital in the year 
1935 is sufficient support of the above statement. It will be 
observed that the annual fatality rate as shown in Table I. varies 
widely, the extremes in adjacent years 1935-36 being 11.1 per cent 
and 25.4 per cent, which show a difference of the order of 100 per 
cent. The low mortality rate in 1935 might have been attributed 
to a new method of treatment had it been instituted in that year, 
so it is not sufficient proof of the efficacy of a new treatment 
to compare the fatality rates in two series of cases in adjacent 
years unless further proof is given that the severity of the ill­
ness was similar. In the two years cited above, there were some 
slight variations in the type of infecting organism in the two
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groups of cases, but this is insufficient to explain more than a 
fraction of the observed difference. That this is so, can be 
shown by applying to the number of cases in each group, according 
to the organismal type in each of the two years, the general type 
specific fatality rate for the whole series of years as follows:
TABLE II.
Type
Percentage
Fatality
(1933-1938)
Number of1 
Cases 
1935
Expected
Deaths
Number of 
Cases 
1936
Expected
Deaths
I. 7.5 28 2.100 20 1.500
II. 30.7 44 13.508 30 9.210
III. 66.1 7 4.627 4 2.644
IV. 17.9 38 6.802 13 2.327
Total 23.8 117 27.037 67 15.681
Correcting Factor
it it
Rate 1935
27.037/
= 117 = 23.11$
H 1936
15.681/
= 67 * 23.40$
1935
23.8/
= 23.11 = 1.0303
1936
23.8/
= 23.40 = 1.0171
Fatality Rate Standardised for differences of organismal type:
1935 = 11.1 x 1.0303 = 11.430$
1936 = 25.4 x 1.0171 = 25.834$
Crude Standardised
Year Fatality Rate Fatality Rate
1935 11.1 11.4
1936 25.4 25.8
Ratio: 1936/1935 2.29 2.26
It can be observed that the fatality rate in these two 
groups standardised for differences of type of infecting organism 
are 11.4 per cent and 25.8 per cent respectively. In other words,
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the difference in type of infecting pneumococcus only accounts 
for a negligible fraction of the wide variations. It may be, 
however, that other factors, for example, low age group and 
bacteraemia rates, were responsible for the lower fatality rate 
In the year 1935.
5. Extent of Lung Involvement.
In this investigation, the extent of the lung involve­
ment was measured in terms of lobes and the average extent of 
involvement in the two series by dividing the number of lobes 
involved by the total cases in the series. It is reasonable to 
assume that this is an important factor in assessing the probable 
outcome of pneumonia since the toxaemia increases with the involve­
ment of the lung tissue.
6. Invasion of the Blood Stream.
The importance of bacteraemia in determining the 
probable outcome of pneumonia is discussed fully in a later 
chapter where it is seen that bacteraemic cases are more serious 
than non-bacteraemic and even more important is the extent of the 
bacteraemia as gauged by the number of colonies present in 1 c.c. 
of blood.
7. White Cell Count.
While the total leucocyte count is a guide in prognosis 
even more valuable information as to the severity of the toxaemia 
is obtained from the differential count as advocated by Schilling. 
The importance of this latter factor is demonstrated in Chapter
II.
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8. Initial Temperature, Pulse and Respiration Rates.
Here again these factors are taken as indicative of 
the degree of toxaemia. The temperature, however, is not such 
a reliable guide as the pulse and respiration rates, as both 
very high and subnormal temperatures point to a marked toxaemia.
With all these variables in patients and in invading 
organisms, it is difficult to determine whether lives are saved 
by any new therapeutic measure. It is insufficient to compare 
the results in a treated series with those in an untreated series 
unless it can be shown that the patients in each series had 
initially the same chances of recovery.
This involves comparing two series of cases which are 
similar as regards the factors which will influence the probable 
outcome of the disease. If these standards are applied, there 
must be a sufficient number of patients in each series so that 
the difference in death rate will be of such a magnitude that it 
can be said with reasonable safety that the lower death rate is 
attributable to the new therapy and not to a chance difference 
in groups of patients selected for comparison. In this investi­
gation, the results have been put to the appropriate statistical 
tests.
COMPOSITION OF CONTROL GROUP.
The control group utilised for the purposes of compari­
son comprises 67 patients admitted to hospital suffering from 
pneumococcal pneumonia during the first half of the year 1938, 
before the advent of Sulphapyridine. Since some of these 
patients, 28 in all, in addition to the usual routine treatment, 
received varying doses of antipneumococcal serum and since I 
have utilised both serum and non-serum treated cases together, 
it is essential firstly to show that in this limited experience,
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there is no evidence of significant difference of outcome, 
attributable to the use of this additional therapy. Actually, 
with the small figures available, I make no claim that the 
statistical insignificance in outcome is in any way proof that 
benefit is not to be obtained from the use of serum. The follow­
ing Tables III. to VII. give an analysis of some of the factors 
investigated in the non-serum and serum treated cases on admission 
to hospital while the others are detailed in the Appendix Tables. 
The mean values of the variable factors are submitted in Table 
VIII.
TABLE III. 
AGE INCIDENCE.
Age in Years
llon-Serum Treated Cases Serum Treated Cases
Deaths Recoveries Deaths Recoveries
10-20 7 1 9
21-30 1 8 1 6
31-40 2 5 2 4
41-50 - 2 - 3
51-60 5 5 2 -
61- 3 1 - -
Total 11 28 6 22
TABLE IV.
DAYS ILL WHEN ADMITTED TO HOSPITAL.
Days
Non-Serum Treated Cases Serum Treated Cases
Deaths Recoveries Deaths ,Recoveries
1st. 1 2
2nd. 3 5 2 6
3rd. 3 3 1 10
4th. 2 7 2 4
5th. 2 5 - -
6 th. 1 6 - -
7th. - 1 - -
8th. - 1 — —
11 28 6 22
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TABLE V.
EXTENT OP CONSOLIDATION MEASURED IN LOBES.
dumber of1 
Lobes
Non-Serum Treated Cases Serum frosted Cases
Deaths Recoveries Deaths Recoveries
1 1 23 1 11
2 5 5 5 9
3
4
5
-
2
11 28 6 22
TABLE VI.
TOTAL WHITE CELL COUNT.
Total Count
Non-Serum Treated Cases Serum Treated Cases
Deaths Recoveries Deaths Recoveries
Under 10,000 4 3 3 3
10,000-15,000 3 8 2 6
15,000-20,000 1 7 - 1
20,000-30,000 2 4 1 5
30,000-40,000 1 6 - 4
40,000 and over - - - 3
11 28 6 22
TABLE VII. 
INCIDENCE OP BACTERAEMIA.
Blood Non-Serum Treated Cases Serum Treated Cases
Culture Deaths Recoveries Deaths Recoveries
Positive 4 2 2 3
Negative 7 26 4 19
11 28 6 22
45
TABLE VIII.
MEAN VALUES OF VARIABLE FACTORS.
Non-Serum Treated 
Cases
Serum treated 
Cases
Number of Patients 39 28
Age of Patient (Years) 37.5 28
Day of Illness 4.2 2.7
Number of Lobes involved 1.5 1.6
Temperature 101.3 102.2
Pulse Rate 117.8 122.7
Respiration Rate 32.2 36.1
Total White Cell Count 17321 20825
Myelocytes and Juveniles 533 543
Stab Cells 3961 4808
Segmented Polymorphonuclears 10963 130012
Lymphocytes 1212 1391
Monocytes 651 717
Tests of statistical significance have been applied to 
each of these observed differences and it is found that in respect 
of age of patient, days ill when admitted to hospital and initial 
temperature, do the two series differ significantly (see Appendix
I.). Since the serum treated patients were younger and were ad­
mitted to hospital earlier in the illness, one would expect the 
serum treated cases would show, other things being equal, a lower 
ultimate fatality rate. The outcome for the two groups of 
patients is shown in Table IX.
TABLE IX.
Non-Serum Treated 
Cases
&erum Treated 
Cases Total
Deaths 11 6 17
Recoveries 28 22 50
39 28 67
The fatality rate in the serum treated cases is 21.4 
per cent, while in the non-serum treated cases it is 28.2 per
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cent. While this appears to be greatly in favour of the serum 
treated, in actual fact, when the appropriate statistical test 
is applied (see Appendix II.), the difference in fatality rate 
is of an order such as readily might have occurred by chance.
The above evidence is obviously ample justification
for amalgamating the two series, serum and non-serum treated 
cases to constitute the "control” group to be used as a contrast 
to a series of cases treated with Sulphapyridine.
EVALUATION OF PROGNOSTIC FACTORS.
The general results of the investigation are presented
in Table X. wherein the cases are sub-divided into these ending
by crisis, lysis and death and the mean values of the character­
istics are set out together with the number of bacteraemic cases 
and distribution according to organismal type of pneumococcus. 
The mean values and the tests of significance were calculated 
from the individual observations. In the Appendix Tables, all 
the variables are presented as grouped frequency distributions, 
so slight differences from the figures given in Table X. may be 
found if they are re-calculated from the grouped data.
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TABLE X .
MEAN VALUES OF VARIABLE FACTORS IN THE THREE GROUPS OF CASES.
Crisis , Lysis Death Total
Age (years) 28.11 32.27 45.94 33.57
Day of Admission 3.86 3.20 3.24 3.55
Number of Lobes involved 1.29 1.60 2.18 1.58
Temperature 101.86 101.52 101.52 101.70
Pulse Rate 117.91 118.13 125.53 119.90
Respiration Rate 33.43 34.40 36.94 34.54
Total Leucocytes 20,103 22,400 12,882 18,785
Myelocytes and Juveniles 288 371 1,196 537
Stab Cells 3,619 5,025 5,116 4,314
Segmented Polymorphonuclears 13,848 14,194 5,548 11,819
Lymphocytes 1,522 1,325 768 1,287
Monocytes 826 818 254 679
Day of Crisis, Lysis or Death 6.63 8.67 7.00 7.18
Positive Blood Culture 4 1 6 11
(11.4$) (6.7$) (35.3$) (16.4$)
Type of Organism I. 16 7 1 24
II. 11 6 12 29
III. 1 1
IV. 1 1
V. 1 1
VI. 1 1
VIII. 2 1
XI. 1 1
XIV. 1 1
XVIII. 2
XIX. 1 1
XX. 1 1
XXXIII. 1 1
Percentage Distribution
of White Cells
Myelocytes and Juveniles 1.4 1.7 9.3 2.9
Stab Cells 18.0 22.4 39.7 23.0
Segmented Forms 68.9 63.4 43.1 62.9
Lymphocytes 7.6 5.9 6.0 6.9
Monocytes 4.1 3.7 2.0 3.6
Number of Cases 35 15 17 67
It will be observed from the above Table X. that in 
many of the investigated factors, wide differences from the 
general average are found in the three groups of cases. Compar­
ing these which ultimately died with the general average, it will 
seen that these which terminated fatally have a higher age, a
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more marked involvement of lung tissue, somewhat higher pulse 
and respiration rates and as regards the blood count, a lower 
total white cell count with a greater 1 shift to the left”, i.e. 
a higher proportion of primitive white cells and a lower number 
of segmented polymorphonuclears and a lower number of lymphocytes 
and monocytes. In addition, the percentage of cases with a bac­
teraemia is higher and the type of infecting organism is quite 
different. Further, in some characters, namely, age of patient, 
extent of lung involvement, initial temperature, pulse and 
respiration rates, number of primitive leucocytes and lymphocytes, 
there is an apparent trend, cases ending by crisis showing the 
highest (or lowest) and cases ending by death showing the lowest 
(or highest) values, with the figures for cases ending by lysis 
intermediate in value. On investigation, however, the differences 
between cases ending by crisis and lysis are quite insignificant 
statistically.
Comparison between these cases which terminated fatally 
and these which recovered and assessment of the statistical sig­
nificance of the data analysed, reveals the differences in the 
number of days ill on admission to hospital, initial temperature, 
pulse and respiration rates, number of stab cells in the blood 
and day of termination are quite insignificant. The remaining 
differences are, however, highly significant, particularly in 
the case of age of patient, the extent of lung involvement, two 
facts which are already well known, but also in regard to the 
number of segmented polymorphonuclears, juvenile forms, myelocytes 
and monocytes in the blood. The statistical tests of these con­
clusions are submitted in the Appendix Tables (see Appendix III.).
The number of cases with a bacteraemia was 6 out of 17
or 35 per cent in those which terminated fatally and 5 out of 50
or lo per cent in those which recovered. While the difference
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looks very apparent, the appropriate statistical test proves 
that it is just significant. (See Appendix IV.).
The complete distribution of the types of pneumococci 
responsible for the infection is set out in Table X. but the 
number of cases in each sub-group is too small to draw trustworthy 
conclusions in respect of individual types. The outstanding 
feature on inspection, however, is the large number of Type II. 
pneumonias which ended fatally, 12 out of 17 or 70.6 per cent, 
whereas, in the recovery group only 17 out of 50 or 34 per cent 
were due to Type II. organisms. This difference is quite signi­
ficant statistically. (See Appendix V.).
Conclusions:
1. The "control” series being heterogeneous in respect
of treatment, (a proportion having had antipneumococcal 
serum and the remainder the usual routine nursing treat­
ment) statistical tests have been carried out to justify 
the amalgamation of the two series to constitute the 
"control11 group. Thus, it has been shown that initially 
the differences between the groups are only in isolated 
phenomena of age of patient, days ill when admitted to 
hospital and temperature on admission to hospital. Of 
these, the latter two are shown subsequently to be of 
no prognostic significance and the difference in the 
ages of the patient is such as to produce, other things 
being equal, a lower fatality rate among the serum 
treated cases. In actual fact, the fatality rate is 
rather lower but the difference for such a small series 
is quite insignificant statistically. I have, therefore, 
every justification in utilising the joint series of 
67 cases as comparative material for the attempted
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evaluation of Sulphapyridine in the treatment in 
pneumococcal pneumonia.
2. The prognostic significance of certain variable factors
has been evaluated. It has been shown that age of 
patient, extent of lung involvement and the number of 
segmented polymorphonuclears, juvenile forms, myelocytes 
and monocytes present in the blood are highly signifi­
cant in this respect and that in addition the total 
white cell count, the presence or absence of bacteraemia 
and the type of infecting pneumococcus are also signi­
ficantly differentiating factors. I am well aware that 
some, perhaps even all, of these are highly correlated 
among themselves and that accordingly these are not 
independent factors of probable outcome, but my series 
is too small to attempt anything in the nature of a 
partial correlation, and, for my immediate purpose, it 
is not at all necessary. The main object here has been 
to isolate the phenomena significantly related to the 
outcome of the disease with a view to assuring myself 
that in respect of these significant differential factors, 
the “controls” are or are not different from the series 
of cases treated with Sulphapyridine. Since this point 
is now quite evident, I will utilise these findings in 
the succeeding pages.
3. Interesting superficially were the differences in the
cases which recovered by crisis and those which re­
covered by lysis. The values found for the latter 
cases in some of the criteria examined were intermediate 
between those for the fatal cases and recoveries by 
crisis. Analysis, however, fails to reveal any
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significance attaching to these differences and in 
the limited experience available, I can only conclude 
that there is no real difference between cases ter­
minating by crisis or lysis.
COMPARISON OP CONTROL CASES WITH 
SULPHAPYRIDINE TREATED CASE'sT"
All the phenomena observed initially, clinical and 
laboratory, are tabulated below with the exception of the temper­
ature, pulse and respiration readings and differential blood 
count, which for the sake of space, are detailed in the Appendix 
Tables. The Tables presented show for each criterion, the dis­
tribution in each group, control and Sulphapyridine treated series 
and for the total cases, while each sub-group is further sub­
divided to show deaths and recoveries separately.
TABLE XI.
AGE INCIDENCE.
Age In Years Contro] Cases
Sulphapyridine 
Treated Cases Total
Deaths Recoveries Deaths Recoveries
10-20 1 16 22 39
21-30 2 14 - 18 34
31-40 4 9 1 16 30
41-50 - 5 2 7 14
51-60 7 5 5 13 30
61 and over 3 1 4 2 10
17 50 12 78 157
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TABLE XII.
DAYS ILL WHEN ADMITTED TO HOSPITAL.
Days Control Cases
Sulphapyridine 
Treated Cases Total
Deaths Recoveries Deaths Recoveries
1st. 1 2 2 5
2nd. 5 11 2 10 28
. 3rd. 4 13 2 19 38
4th. 4 11 3 24 42
5 th. 2 5 3 14 24
6th. 1 6 - 3 10
7 th. - 1 - 3 4
8th. - 1 2 3 6
17 50 12 78 157
TABLE XIII.
EXTENT OF CONSOLIDATION MEASURED IN LOBES.
Number of 
Lobes
Control Cases
Sulphapyridine 
Treated Cases Total
De aths Recoveries Deaths Recoveries
1 2 34 3 48 87
2 10 14 3 23 50
3 5 2 5 6 18
4 - - 1 1 2
17 50 12 78 157
TABLE XIV.
TOTAL WHITE CELL COUNT
Total Count Contro^L Cases
Sulpha*
Treated
>yridine
Cases Total
Deaths Recoveries Deaths Recoveries
Under 10,000 7 6 3 4 20
10,000-15,000 5 14 5 17 41
15,000-20,000 1 8 1 13 23
20,000-30,000 3 9 3 26 41
30,000-40,000 1 10 - 15 26
40,000- - 3 «* 3 6
17
1
50 12 78 157
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TABLE XV. 
INCIDENCE OP BACTERAEMIA.
Sulpfiiapyridine
Blood Control Cases Treated Cases Total
Culture , Deaths Recoveries Deaths ftecoveries
Positive 6 5 9 14 34
Negative 11 45 3 64 123
17 50 12 78 157
TABLE XVI.
-- Total' Serie s Means
d
<Td P.Mean
Standard 
Devi­
ation , Control,
Sulpha­
pyridine
Treated
Age 34.9205 15.9280 33.8435 35.7225 0.7313 0.46
Lobes involved 1.5860 0.7405 1.5672 1.6000 0.2746 0.78
Day of
Admission 3.8153 1.5468 3.5522 4.0111 1.8389 0.07
Temperature 101.4459 1.3373 101.6955 101.2600 2.0186 0.045
Pulse Rate 118.5732 14.1548 119.6416 117.7778 0.8162 0.41
Respiration
Rate 36.0036 6.5362 34.5374 37.2000 2.5243 0.01
Total White
Count 20,541 9,831 19,388 21,400 1.2680 0.21
Myelocytes &
Juveniles 585 829 557 606 0.3595 0.72
Stab Cells 5,123 1,235 4,317 5,722 2.8266 7.01
Segmented
Forms 11,914 7,393 11,813 11,989 0.1469 0.88
Lymphocytes 1,630 1,092 1,510 1,719 2.3657 0.02
Monocytes 809 743 • 699 890 I1.5916 0.11
Total Series Means
Mean Control Sulphapyridine Treated
Myelocytes &
Juveniles 2.9 3.0 2.9
Stab Cells 25.e 22.8 27.3
Segmented
Forms 59.4 62.5 57.3
Lymphocytes 8.1 8.0 8.2
Monocytes 4.0 3.7 4.3
In Table XVI. are presented the basic comparative data 
Tor the control and Sulphapyridine treated cases, together with 
the corresponding values for the whole series of cases combined.
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As an estimate of the variability of each of these factors, the 
standard deviation of the whole distribution is used and it is 
this which has been taken in the calculation of the standard 
error of the individual differences.
The ratio of the differences between the mean values 
of the two groups to the standard error and the corresponding 
probability (P) that the difference might arise by chance are 
tabulated. (If the difference divided by the standard error of 
difference does not exceed 2.0, there is no adequate reason for 
believing that the two groups differ in that particular feature).
Scrutiny of Table XVI, indicates that statistically 
significant differences between the control and Sulphapyridine 
treated cases are found in respect of day of admission, initial 
temperature and respiration rate and the number of stab cells, 
and lymphocytes present in the blood. The control cases show a 
rather earlier date of admission to hospital, higher initial 
temperatures and lower respiration rates. In respect of each 
of these three factors, the analysis carried out in a previous 
section indicates that any such differences will not significantly 
influence the outcome of the illness and may, therefore,be ignored 
as influential factors since ultimately the case for or against 
the new treatment by Sulphapyridine rests on the resultant fatality 
rate. As regards the blood findings, wherein the two groups differ 
substantially, the prognostic import is difficult to assess as the 
two series differ only in respect of the numbers of stab cells and 
lymphocytes. If, instead of reviewing the total count, attention 
is directed to proportional distribution of the cells, it can be 
seen from Table XVI. that the Sulphapyridine treated series differs 
from the control series in having a lower percentage of segmented 
polymorphonuclears and a higher percentage of stab cells, both 
of which are unfavourable prognostic factors, but a higher
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proportion of monocytes, a favourable prognostic sign. Thus, 
even in respect of proportional distribution, it is difficult to 
assess the ultimate weighting of the balance, since it may be 
that discrepancies on either side will balance each other.
The blood culture findings in the two series are seen 
in Table XVII.
TABLE XVII.
RESULTS OP BLOOD CULTURES.
Blood Culture Control Cases
Sulphapyridine 
Treated Cases Total
Positive 11 (16.4$0 23 (25.650 34
Negative 56 67 123
67 90 157
It will be seen that while 16.4 per cent of the control 
cases showed invasion of the blood stream, a much higher proportion 
of the Sulphapyridine treated cases, 25.6 per cent had a bacter­
aemia. The difference of 9.2 per cent seems appreciable but as the 
standard error of the difference is 6.6, the actual difference is 
9.2 * 6.6, which is not significant statistically, i.e., the dif­
ference is of such a magnitude as might frequently have arisen 
purely by chance. Although statistically insignificant, however, 
the difference, it will be noted, is unfavourably weighting the 
outcome of the Sulphapyridine treated series. The fatality rate 
in the bacteraemic cases treated with Sulphapyridine was 39 per 
cent.
TYPE OP INFECTING ORGANISM AND DEATHS 
ACCORDING TO TYP# OF ORtiAlfrlflM.
The types of organism responsible for the infection 
in the two series of cases are as follows!- the types are
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designated Type I., II., III. and Group IV., since the sub­
division of the Group IV. organism would make the numbers in 
the sub-group too small, and little is known regarding the 
fatality of the higher types of pneumococci occurring in this 
part of the country. The complete type distribution is set out 
in the Appendix Tables.
The expected deaths have been calculated from the type 
fatality rate over a period of six years in Knightswood Hospital.
TABLE XVIII.
Type
of
Organism
Control Cases
Sulphapyridine 
Treated Cases
Number
and
Per­
centage Deaths
Expected
Deaths
Number 
and 
Per­
cent age Deaths
Expected
Deaths
Total
I. 24
(35.8)
1 1.8 11
(12.2)
1 0.8 35
II. PQ
(43.3)
12 8.9 34
(37.7)
2 12.3 63
III. 1
(1.6)
1 0.6 12
(13.3)
6 8.0 13
Group IV. 13
(19.1)
3 2.3 33
(36.6)
3 5.9 46
67 17 13.6 90 12 27.1 157
There is a striking difference in the type of 
pneumococcus responsible for the infection in the two series of 
cases. Type I. infections, which usually have the lowest fatality 
rate (7.5$) are much less frequent in the Sulphapyridine series, 
but against this the Sulphapyridine series has a higher porportion 
of Group IV. infections which over the last 6 years in Knightswood 
Hospital had a fatality rate of 17.9 per cent, the next lowest to 
Type I.
57
The proportion of Type II. cases is slightly higher in 
the control series hut the most striking difference is the higher 
proportion of Type III. infections (13.3$) in the Sulphapyridine 
series, an infection which is associated with a fatality rate of 
66 per cent during the six year period at Knightswood Hospital.
So, as regards type of infecting organism, the Sulphapyridine 
series is more conducive to a higher fatality rate. How much 
this factor alone might be responsible for differences in mortal­
ity quite apart from any specific treatment is evidenced by the 
fact that if the fatality rates for the separate types of 
pneumococcal pneumonia given in Table I. are applied to the num­
ber of cases in each of the two groups, the expected fatality 
rates, in respect of Type III. infections, would be in the control 
series 20.43 per cent, in the Sulphapyridine treated series 27.89 
per cent, as excess of roughly one third in the latter series, 
due solely to the unfavourable type of organism which comprises 
the series.
Thus it will be seen that for the analysis of the 
variables in the patients and invading organism, which influence 
the outcome of pneumonia, apart from any specific treatment, the 
chances of recovery were less in the Sulphapyridine treated series 
than in the control series.
COMPARISON OF FATALITY RATES IN THE TWO SERIES.
The fatality rates in the two series are detailed in
Table XIX.
TABLE XIX.
Control Series
Sulphapyridine 
Treated Series Total
Deaths 17 (25.4$) 12 (13.3$) 29
Recoveries 50 • 78 128
Total 67 90 157
58
The difference in fatality rates for the two series is 
12.1 per cent and the standard error of difference 6.26, so that 
the actual difference is 12.1 * 6.26, a figure which just falls 
short of attaining the conventional level of significance. Be­
sides this fact, however, we have to place, especially, two con­
siderations, namely, the higher incidence of bacteraemia and the 
significantly less favourable type distribution of the pneumococcus 
in the Sulphapyridine series. Since the difference in fatality 
rates is just approaching the level of significance and since 
allowance for the difference in type of infecting organism and 
incidence of bacteraemia would magnify the fatality differences, 
the resulting fatality rates, corrected for initial differences 
in the two series, indicate a definite benefit from the new form 
of therapy.
Before drawing conclusions, I would like to refer again 
to Marriott’s publication in the British Medical Journal in which 
he reviews 1991 cases of pneumonia treated with Sulphapyridine 
with a fatality rate of 5.5 per cent. While the fatality rate, 
in my series, is much higher, it should be borne in mind that 50 
per cent of the fatalities occurred in Type III. pneumonias, which 
would seem to question Marriot!s statement that Sulphapyridine is 
”very effective against pneumococci of all types” and this state­
ment should be regarded with caution until further proof of the 
effect of Sulphapyridine in Type III. pneumonias is forthcoming. 
Furthermore, inspection of Table XVIII. reveals that the reduction 
in fatality in the Sulphapyridine treated series is confined 
chiefly to the Type II. cases, which would seem to indicate that 
the action of the new drug has some degree of specificity.
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Conclusions:
1. Before drawing conclusions regarding the efficacy of
Sulphapyridine treatment of pneumococcal pneumonia, 
comparison of fatality in a treated and untreated 
series must be made and one must be satisfied that 
the two groups of cases are for practical purposes 
similar.
2. In the two series investigated in this work, from a
prognostic point of view, the Sulphapyridine treated 
cases were of more serious import in respect, chiefly, 
of two points:
(a) Proportion of cases with a bacteraemia.
(b) Type distribution of the pneumococcus.
The unfavourable type distribution of the pneumococcus 
in the Sulphapyridine treated series was estimated as 
likely to produce a fatality rate one third as high 
again as in the control series.
3. Comparison of the fatality rates, in spite of the above
considerations, shows a lower death rate in the series 
of cases treated with Sulphapyridine
4. While Sulphapyridine has reduced the mortality rate, I
can lay claim to no such phenomenal reductions as de­
scribed by some other workers. As this is undoubtedly
due to the high percentage (50$) of deaths in Type III.
infections, it is felt that a very low fatality rate, is 
in fact, due to the absence of severe infections. I 
have presented sufficient evidence here to show how 
wide can be the differences in fatality rates and com­
position of successive groups of pneumonia cases, in 
respect of really vital factors in outcome, evidence
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wholly sufficient to cast doubt on the assumption, 
that groups taken in any manner other than by complete 
random grouping can, without adequate presentation of 
the actual data, be accepted as comparable.
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CLINICAL AND BACTERIOLOGICAL INVESTIGATIONS IN PATIENTS 
UNDERGOING SULPHAPYRIDINE TREATMENT.
The effect of Sulphapyridine on the fatality rate 
based on the treatment of 90 patients suffering from pneumococcal 
pneumonia has been discussed in a foregoing chapter. It is the 
object of this chapter to make a study of the effect of Sulpha­
pyridine on the course of the illness, together with an investi­
gation of the blood picture and bacteraemia In these patients 
under treatment, in an endeavour to throw some light on the 
mechanism of action of the new drug.
A. EFFECT ON TEMPERATURE, PULSE AND RESPIRATION RATES 
AND PATHOLOGICAL CONDITION OF LUNGS.
Apart from the reduction in fatality rate from 27 per
cent in a control series, to 8 per cent in the treated series of
100 patients, Evans and Gaisford (1938) pointed out that one of 
the most striking effects of Sulphapyridine was the immediate, 
almost dramatic, fall in temperature, irrespective of the type 
of infecting pneumocossus and stage of illness at which treatment 
was instituted, accompanied by an immediate improvement in the 
clinical appearance of the patient. While the former of these 
statements was borne out in this investigation, as is shown in 
the tables below, the fall in temperature was out of all pro­
portion to the improvement in the general condition of the 
patients under treatment and it must not be assumed that Sulpha­
pyridine, by causing an immediate fall in the temperature brings 
about a crisis in the true sense of the word. Since about 70 per 
cent of the patients suffered from nausea and vomiting at some
time or other during treatment, it was quite usual for them to
complain of feeling worse in spite of having a normal temperature 
and a lower pulse and respiration rate, also the feeling of well
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being which normally accompanies a natural crisis was absent.
It was quite usual for very ill patients to be wildly delirious 
for several days, although the temperature was normal.
But a fact which was almost as striking as the fall in 
temperature was the delay in normal resolution in the lung tissue, 
often accompanied by the persistence of pleural pain. Unless in 
very mild cases, signs of resolution which usually accompanies a 
crisis were absent and in 48 per cent of the patients}resolution 
was delayed for varying periods up to three weeks after the 
temperature had reached normal and 7 per cent of these were im­
perfectly resolved on dismissal from hospital. It is too early 
yet to attempt to assess the remote effects of Sulphapyridine 
treatment of pneumonia,but it would not be surprising if there was 
a rise in the incidence of the more chronic chest affections.
Superficial scrutiny of the patients in whom resolution 
was delayed gave one the impression that in patients who had been 
treated early in the disease the lung condition was slower in re­
solving, but analysis proved that this was not the case, and that 
delay in resolution bore no relationship to the duration of the 
disease at which treatment was instituted.
The effect of Sulphapyridine on the pathological course 
of lobar pneumonia is imperfectly understood, but it in some way 
interferes with the normal course of events or the stages of red 
hepatisation, white hepatisation and resolution. This may be 
illustrated by the following case. A woman, aged 53 years, was 
admitted to hospital on the 2nd. day of illness, suffering from 
a Type VIII. pneumonia involving the entire right lung with the 
exception of the apex. The physical signs of massive consolida­
tion persisted for the next week and there were neither signs of 
resolution in the affected lung nor a spread of the pneumonia and, 
as indicated by temperature, pulse and respiration rates, the
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patient had a good response to treatment. Death occurred 
after 8 days in hospital and the patient had a rising leucocyte 
count during her last 3 days, the final count reaching the 
high figure of 50,000 cells per cmm. A post mortem examination 
was performed and the entire right lung, with the exception of 
the apex, was found to be in a state of red hepatisation. In 
other words, the pneumonic process had neither spread nor re­
gressed and the pathological process seemed to have been 
arrested. Similarly, in the early stages of the investigation, 
when it was not known how long to continue treatment with the 
drug, it was found, in patients in whom the drug was stopped 
after 48 hours* treatment, i.e., after the initial response, 
there followed a secondary rise in temperature and a continuation 
of the pneumonia from the stage at which it had seemingly been 
arrested.
No cases of empyema or other metastatic spread of the 
pneumococcal infection were encountered in the Sulphapyridine 
treated patients.
Detailed in Table I. are the results of Sulphapyridine 
on the temperature, pulse and respiration rates in patients 
suffering from pneumococcal pneumonia.
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It will be seen that, in all the cases, irrespective 
of the type of pneumococcus responsible for the infection, the 
fall in temperature to normal was immediate, and was accompanied 
by a less rapid fall in the pulse and respiration rates. This 
latter fact was to be expected in view of the persistence of 
physical signs of consolidation In the lungs, and it was found 
that the more ill patients tended to have the more rapid pulse 
and respiration rates.
There was no apparent difference in the temperature 
readings in the deaths and recoveries and although the number of 
deaths in the various groups are too small to draw conclusions, 
it is noteworthy that the pulse and respiration rates in the 
deaths remained at a higher level in spite of the fall in temper­
ature .
Conclusions:
1. In the treatment of pneumonia with Sulphapyridine,ir­
respective of the day of illness on which treatment
is instituted, there occurs an immediate fall in
v
temperature.
2. The fall in temperature in patients undergoing treatment,
is accompanied by a fall in the pulse and respiration
rates which, however, is not so immediate.
3. Clinical improvement in the patients is not in the same
proportion to the fall in temperature, i.e. a true
crisis does not take place.
4. Delay in resolution of lung tissue occurs in a large
proportion of patients treated with Sulphapyridine.
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B - leucocyte count in sulphapyridine treated patients
Leucocyte counts were performed on each patient on ad­
mission to hospital before the institution of drug treatment, and 
then at daily intervals for varying periods depending on the pro­
gress of the patient. The daily count served two purposes^in that 
it enabled a study to be made of the leucocyte count on patients 
under treatment, and also safeguarded against the overlooking of 
agranulocytosis. The findings of the leucocyte count for the re­
coveries are graphed along with the temperature readings in Chart
I.
It will be observed from Chart I. that, irrespective 
of the Type of pneumococcus responsible for the infection, a fall 
in leucocyte count accompanied the fall in temperature, but the 
fall was not so immediate.
Type I. Cases.
The average admission leucocyte count in 10 patients 
suffering from Type I. pneumonia varied between the figures of
II,000 to 40,000 cells per cmm., the average value being 23,200. 
There was a rapid fall in the average figure until after 72 hours* 
treatment it reached 9,700 cells per cmm.
Type II. Cases.
The average leucocyte count on admission to hospital in 
32 cases of Type II. pneumonia was 19,000 cells per cmm., slightly 
lower than in Type I. cases, and here again the readings showed 
wide variations between the figures of 9,000 and 41,000 cells per 
cmm. Two patients had an admission count of under 10,000 cells 
per cmm. and although this rose on subsequent days with treatment, 
the average daily figures, as is seen in the accompanying graph, 
shows a gradual reduction in the leucocyte count accompanying the 
fall in temperature.
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Type III. Cases.
The average admission leucocyte count in the 6 patients 
suffering from Type III. pneumonia who recovered was 25,000 cells 
per cmm. and the extremes were 16,000 and 35,000 cells per cmm. 
After 72 hours* treatment, the average leucocyte count fell to
i
11,000 cel'ls per cmm.
Group IV. Cases.
Examination of the leucocyte count in 30 patients with 
Group IV. pneumonia showed that the average count on admission to 
hospital was 23,500 cells per cmm., the lowest being 10,000 cells 
per cmm. while the highest admission count was 42,000 cells per 
cmm. As was observed in the other types of infection, the count 
fell to 10,200 cells per cmm. within 72 hours.
Chart II. shows the average daily leucocyte count for 
the 78 patients who recovered with Sulphapyridine treatment.
Only two had an admission leucocyte count under 10,000 cells per 
cmm. In these two patients the count rose to slightly over 10,000 
cells per cmm. and remained about that level. In no case was the 
commencement of Sulphapyridine treatment followed by a rapid rise 
in the leucocyte count and while 6 patients showed a slight rise 
on the following day, the tendency was for the count to approach 
a level between 10,000 and 12,000 cells per cmm. after three days* 
treatment.
Chart III. shows the trend of the average daily leucocyte 
count in the fatal cases compared with the recoveries.
Ba.'j cj-lvcatlnerit
The average admission leucocyte count in the 12 fatal 
cases was 13,400 cells per cmm. compared with 22,600 cells per 
cmm. in the recoveries, and, as can be seen from Chart II., the 
general trend of the two curves on subsequent days is quite dif­
ferent. While a fall occurred in the recoveries in the first 
three days of treatment, the leucocyte count in the fatal cases 
tended to remain at the same initial lower level during the first 
three days, and this was followed by a rise on subsequent days.
A leucocytosis over 40,000 cells per cmm. was observed in 2 cases 
before death occurred which aroused suspicion of pus formation, 
a suspicion which was not confirmed.
Conclusions.
1. During the first three days of treatment of pneumonia 
with Sulphapyridine there is no evidence of a marked
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stimulation of the leucocytes.
2. In successfully treated patients, a fall in the leucocyte
count accompanies the fall in temperature.
3. In fatal cases, the initial leucocyte response is not
so great hut there is evidence of stimulation as the
illness progresses.
4. Sulphapyridine has no apparent deleterious effect on the
circulating leucocytes or hone marrow.
C. SCHILLING COUNT IN SULPHAPYRIDINE TREATED PATIENTS.
The majority of cases of pneumococcal pneumonia are 
accompanied hy a leucocytosis of which 90 per cent are neutrophils. 
In the Schilling count the neutrophils are divided into four 
classes: myelocytes, juvenile forms, stah cells and segmented
polymorphonuclears, which together comprise the Central Quaternary 
Figure. It has heen shown In a previous Chapter that a Mshift to 
the left,T, or an increase of the primitive leucocytes in the 
blood, is the normal accompaniment of pneumonia and that a pro­
gressive decrease in the shift is a sign of favourable prognostic 
import.
Tahle II. details the average readings for the Central 
Quaternary Figure of the patients treated with Sulphapyridine.
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In the recoveries irrespective of the type of pneu­
mococcus responsible for the infection, a progressive "shift to 
the right" or diminution in the primitive neutrophils present in 
the blood can be seen, indicative of a satisfactory response to 
the infection.
As regards the blood picture in the fatal cases, a pro­
gressive "shift to the left" would have been expected but this 
was not experienced. Most of the patients who died improved con­
siderably with the treatment and the average figures for the 
Central Quaternary Figure also showed "a shift to the right" 
which was not so evident as in the recoveries.
Comparison of the percentage of neutrophil polymorphonu- 
clears in the fatal and non fatal cases reveals that initially 
the percentage was 88. On subsequent days the percentage of 
neutrophils decreased in the non fatal cases whereas the high 
figure was maintained in the fatal cases.
Tables III. and IV. detail the average percentage of 
lymphocytes and monocytes in the blood of patients treated with 
Sulphapyridine.
TABLE III. 
PERCENTAGE OF LYMPHOCYTES
Recoveries On Admission 24 Hours 48 Hours 72 Hours
Type I. 8.7 10.6 12.3 17.0
Type II. 9.3 9.4 15.7 16.6
Type III. 6.0 8.0 11.6 14.0
Group IV. 8.7 10.4 16.3 21.8
Average 8.2 9.6 13.9 17.3
Deaths 8.8 6.4 8.5 9.8
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TABLE IV. 
PERCENTAGE OP MONOCYTES.
Recoveries On Admission 24 Hours 48 Hours 72 Hours
Type I. 3.75 5.9 10.4 13.5
Type II. 4.1 5.2 9.8 12.8
Type III. 3.2 4.3 10.3 15.2
Group IV. 4.6 6.0 9.5 11.0
Average 3.9 5.3 10.0 13.1
Deaths 2.9 3.0 4.5 5.6
As can be seen from Tables III. and IV., there was a 
greater rise in the percentage of lymphocytes and monocytes in 
the patients who recovered. While a slight increase in the per­
centage of lymphocytes and monocytes was experienced in fatal 
cases, a rapid increase may be regarded as an indication of a 
satisfactory response to treatment.
An absence of eosinophils and basophils from the blood 
is the usual finding in pneumonia and this was borne out during 
the investigation. While an eosinophilia may be encountered 
after a normal crisis, blood examinations were only pursued for 
three days after the institution of treatment, except in exception­
al cases. Consequently, there is insufficient data to make ob­
servations on the course of the eosinophil count. In some cases, 
eosinophils were encountered within three days of institution of 
treatment.but no marked stimulation of the eosinophils was ob­
served.
Conclusions.
1. Observations on the Schilling Count in patients treated 
with Sulphapyridine show that a 11 shift to the right** 
occurs with treatment •
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2. The degree of "shift to the right" is an indication 
of the patientfs response to treatment. A greater 
"shift" is found in patients who recover together 
with a more rapid increase in the lymphocytes, and 
monocytes.
D. BACTEHAEMIA IN SULPHAPYRIDINE TREATED PATIENTS.
The presence of bacteraemia in pneumococcal pneumonia 
has long been recognised, and while it is of little value in the 
diagnosis of the disease, it has proved to be of some value in 
prognosis. The frequency with which bacteraemia occurred led to 
the erroneous view propounded by Leslie (1924) and Norris and 
Parley (1925) that pneumonia was primarily a generalised infection 
with a subsequent localisation in the lungs. This has since been 
disproved by the analysis of patients on whom blood cultures were 
performed during the initial stages of the illness. Glynn and 
Digby (1923) showed that blood cultures taken during the first 
three days of illness yielded a small percentage of positive re­
sults compared with blood cultures taken at a later date. These 
findings are in keeping with the results obtained by Blake and 
Cecil (1920) in their work on the experimental infection of 
monkeys with pneumococci.
In this investigation, blood cultures were performed on 
165 patients and 44 gave a positive result. In six instances the 
blood was positive on the second day of illness, nine on the third 
day, while the remaining positive cultures occurred at a later 
date.
The number of patients in whom a bacteraemia is detected
depends on the technique used in cultivation, and also on the
frequency of examining blood samples. The following Table V.
«
shows the wide variations in the percentage of bacteraemlc cases 
obtained by individual workers.
TABLE V.
Number of 
Patients
Percentage of 
Positive Results
Prochaska (1901) 40 100 per cent
Rosenow (1904) 175 91 " »
Mathers (1915) 128 75 n n
Urquart (1921) 34 55.8 w M
Christie (1933) 120 45 ” t
Langley (1933) 200 40.5 " n
Hart (1919) 96 39.5 w it
Cecil et al. (1927) 107 34.5 " ti
Avery et al. (1917) 448 30.3 M it
Cruickshank (1933) 329 25.5 ” it
Schottmuller (1905) 227 23. H it
Rosenbluth (1928) 500 22.4 " it
In the course of this study of 165 patients on whom 
hlood cultures were performed, 44 or 26.6 per cent yielded a 
positive result. This figure is somewhat lower than most of the 
results recorded above, which would seem to indicate that the in­
fection dealt with,was of a milder nature. While this may be so, 
it must be borne in mind that 90 of the patients were treated with 
Sulphapyridine after a preliminary culture had been taken, and in 
no instance was a positive result obtained from a case which had 
a negative culture before treatment was instituted.
The results of this investigation detailed according to 
type of infecting organism were as follows.
TABLE VI.
RESULTS OP BLOOD CULTURES IN 
165 Cases of PneumOCOcCAL pnETTMCn i a.
Type of 
Pneumocossus Number of Cases Positive Cultures Percentage
Type I. 36 2 5.5$
Type II. 64 18 28.1$
Type III. 18 12 66.6$
Group IV. 47 12 25.5$
Total 165 44 26.6$
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Perhaps the most striking feature was the low percentage 
of positive results obtained in Type I. cases which was in keeping 
with the relatively mild form of the illness encountered. Group 
IV. infections, on the other hand, showed a moderately high per­
centage of positive results, four times as high as the Type I. 
cases. By far the highest percentage of positive cultures was 
obtained in Type III. infections.
BACTERAEMIA AND PROGNOSIS IN PNEUMONIA.
It was shown by the Rockfeller workers (1917) that not 
only did the severity of pneumonia vary with the type of infect­
ing organism, but also that bacteraemic cases tended to be more 
severe and often terminated fatally. In their investigation of 
135 bacteraemic cases, 55.8 per cent proved to be fatal, whereas 
the mortality rate was only 8.3 per cent in 312 cases with 
negative blood cultures. These findings were confirmed by 
Rosenbluth (1928) and by Park, Bullowa and Rosenbluth (1928).
While Christie (1933) working in this hospital did not find such 
a close correlation between the presence of a bacteraemia and 
mortality, that was possibly due to the fact that blood cultures 
were performed daily in his cases and this enabled him to detect 
transient bacteraemias.
The mere presence or absence of a bacteraemia is not, 
however, of such importance in prognosis as the degree of bacter­
aemia and the stage of the illness at which it occurs. As regards 
the former, the Rockfeller workers (1917) dealing with Type II. 
infections, found that the prognosis was hopeless if patients had 
more than 15 colonies of pneumococci in 1 c.c. of blood, while 
Rosenbluth (1928) showed that irrespective of the type of infects 
ing organism, patients with more than 24 colonies per c.c. of ' 
blood seldom recovered. Christie (1933)* however, reported two 
Patients who recovered in spite of a comparatively high degree of
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invasion of the blood stream - one a Type I. infection with 15 
colonies per c.c. and the other a Type III. infection with 40 
colonies per c.c. of blood.
As regards the stage of illness at which the bacter­
aemia occurs, again it was shown by the Rockfeller workers (1917) 
that cases in which the blood was invaded later in the illness 
often had a fatal termination. This was confirmed by Rosenbluth 
(1928) and Cecil and Plummer (1932). Christie (1933) found that 
mild cases often showed a positive blood culture, transient in 
nature, either early or late on in the illness but a bacteraemia 
which persisted after the 4th. day or became more intense was of 
grave prognostic significance.
Of the 165 patients on whom blood cultures were per­
formed, 90 were treated with Sulphapyridine and these are dis­
cussed later. Twenty-one of the remaining patients had a bacter­
aemia at some stage in the illness. Cultures were taken on ad­
mission and at varying intervals of one, two and three days until 
the time of recovery or death.
The following Table VII. details the degree of bacter­
aemia, the day on which it occurred and the outcome of the illness.
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It will be observed that a large number of cases ex­
hibited a terminal bacteraemia with very high colony counts and 
that these cases belonged to the higher age groups.
Of the five bacteraemic cases which recovered, three 
were treated with type specific antipneumococcal serum and two of 
them developed empyema. These two patients, who had fairly high 
colony counts of 25 and 10 colonies per c.c. of blood respectively, 
had negative blood cultures before the onset of the complication.
SULPHAPYRIDINE IN BACTERAEMIC CASES.
In an article in the Canadian Medical Association 
Journal of April, 1939, Graham et al. made a study of the effect 
of Sulphapyridine on the bacteraemia. In their series of 50 
treated cases, 17 had a positive blood culture. Three cases 
proved fatal - all of these were elderly patients and had a bac­
teraemia with colony counts of 3,000 per c.c. (Type XII.), 15 per 
c.c. (Type XXII.), and 50 per c.c. (Type VIII.). The first of 
these died before blood culture was repeated. The second had a 
negative result after 24 hours* treatment, while the last had 
colony counts of 3,000 per c.c., 280 per c.c. on the two following 
days and on the third day of treatment the blood culture was 
negative. In the last two cases, the bacteraemia, in spite of a 
massive invasion of the blood stream, had been controlled and 
death was attributed to old standing myocardial disease. In 
addition, recovery is reported in.a patient suffering from a Type 
III. infection with 450 colonies per c.c. of blood in whom the 
blood was sterile within 24 hours. Also no cases with a positive 
blood culture were encountered which failed to respond to treat­
ment. These results, in view of the findings of the Rockfeller 
workers (1917) and Rosenbluth (1928) reported above, are dis­
tinctly encouraging and in themselves demonstrate the potency of 
the new drug.
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In this investigation of 90 patients, a preliminary 
blood culture was taken before Sulphapyridine treatment was 
instituted. Blood cultures were then performed at daily inter­
vals until two or three successive negative results were obtained, 
and were only repeated if there was any reason to suspect a re­
lapse in the course of the illness as signified by a rise in the 
temperature, pulse, and respiration rates. The dose of the drug 
given was 2 grammes initially, followed by 1 gramme four hourly, 
making a total of 7 grammes daily. Occasionally, the initial dose 
of 2 grammes was sustained over a period of 24 hours if it was 
thought expedient. The consequent administration of the drug was 
based on the response of the patient.
The following Tables VII-I. - X. detail the effect of 
the drug on the bacteraemia and are set out according to the type 
of organism causing the disease. No cases of Type I. infection 
with a positive blood culture were encountered.
TABLE VIII.
DEGREE OP BACTERAEMIA IN 11 CASES OP TYPE II.
PNEifMbNoCcAL Pneumonia tRMffiD wlto sulpAAPyRI^ine .
Case No. Age Day o:f Illness Result2 3 4 5 6 7 8 9 10
1. 22 + mm Well
2. 18 + — - Well
3. 44 1 - -» Well
4. 32 3 — - Well
5. 25 15 - - Well
6 • 52 20 - - Well
7. 28 25 - - Well
8. 22 40 - - Well
9. 39 80 - - - Well
10. 28 2000 - - Well
11. 57 58 - - Died 7th.Day
Of the 11 Type II. bacteraemic cases of pneumonia 
treated with Sulphapyridine, one died. This patient, 37 years 
of age, was moribund on admission to hospital and had an
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involvement of four of the five lobes of his lungs. His blood 
was invaded to a marked degree, the plate count revealing 58 
colonies per c.c. of blood. Although the blood culture was 
sterile after 24 hours’ treatment with Sulphapyridine and re­
mained sterile^ and his general condition improved during the en­
suing two days, he had a sudden relapse and died on the 7th. day 
of illness. At one time it was thought that the drug was going 
to be instrumental in saving what looked like a hopeless case and 
it is significant that the progressive nature of the lesion, as 
judged by the degree of invasion of the blood stream by the organ­
ism, was arrested.
Of the remaining 10 cases, all of which recovered, 7 
showed only a moderate degree of bacteraemia, up to 25 colonies 
per c.c. of blood,on admission. In none of these cases did the 
organism multiply in the blood and the cultures became sterile 
and remained so after 24 hours’ treatment.
The most striking results, however, were obtained in 
the remaining three patients, in whom the blood was invaded to 
a very marked degree - the plate counts being 40, 80 and 2,000 
colonies per c.c. of blood respectively. All of these patients 
were critically ill on admission to hospital. In all three in­
stances, the blood was sterile after 24 hours’ treatment and re­
mained sterile. Although they were wildly delirious for the en­
suing three or four days, and convalescence was prolonged due to 
a delay in resolution of lung tissue and persistence of pleural 
pain, all of these patients left hospital fully recovered.
These last three cases are especially interesting since 
until the advent of Sulphapyridine, no case of recovery from Type
II. pneumonia with over 40 colonies of pneumococcus per c.c* of 
blood has been reported in medical literature.
82
TABLE IX.
DEGREE OP BACTERAEMIA IN 6 CASES OP TYPE III. 
PNEUMOCOCCAL PNEUMONIA TREATED "WITH 'gtJLPHAPYatfilNE.
Case
No. Age
Day oi" "TTTnesi
Result2 3 4 5 6 7 8 9 10
1. 56 18 _ Well
2. 59 1 - Died 6th.Day
3. 52 110 - - Died 11th.Day
4. 42 380 - - - Died 9th.Day
5. 47 5000 •f - - - - Died 21st.Day
6. 59 + + + 20 320 Died 6th.Day
The Type III. infections were of a very severe nature
and it can be seen that patients admitted to hospital at varying
stages of the illness, from the 2nd. to the 8th. day, showed in­
vasion of the blood stream by the pneumococcus. All of these 
patients were critically ill on admission to hospital and only 
one recovered. He had a fairly severe degree of bacteraemia - 
18 colonies per c.c. of blood - which was successfully combat^ed 
after 24 hours’ treatment. It will be observed that* death oc­
curred in four patients, in whom the bacteraemia, despite the 
extent of it, was immediately and successfully overcome. One of 
these patients had 5,000 colonies of pneumococci in 1 c.c. of 
blood. After 24 hours, the colony count was negative, although
the Hartley’s Broth was positive, and on the following day both
broth and plate count were negative. Although his temperature 
was normal, the patient was still very toxic and incoherent.
The condition of his lungs failed to resolve and he gradually 
became weaker and died on the 21st. day of illness.
In one instance the administration of Sulphapyridine 
had very little effect on the course of the illness and as can 
be seen from the daily result of blood culture, the organism 
actually multiplied in the blood. It is possible that this is 
an example of a drug resistant strain of pneumococcus.
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The effect of Sulphapyridine on the bacteraemia in the
Group IV, cases was not so striking as in the Type I. and Type
II, cases. Six bacteraemic cases of Group IV. pneumonia were 
treated with conflicting results.
An immediate response to treatment was obtained in the 
Type VII. case and also in the Type XXII. case and they both made 
an uneventful recovery. While the Type IV. case also recovered,
It can be observed that the drug had no effect on the bacteraemia, 
which persisted for six days before disappearing.
Two of the remaining patients, one suffering from a 
Type VI. pneumonia and the other from a Type VIII. pneumonia, 
had persistently positive cultures throughout the illness, which 
in both Instances terminated fatally.
The remaining patient, a man suffering from a Type VIII. 
pneumonia, is referred to in detail under the analysis of the
fatal cases. The blood culture was positive on admission to
hospital, became negative after 24 hours1 treatment, became 
positive again when the drug was stopped, and in turn became 
negative when drug treatment was restarted. But what is more 
noteworthy Is the fact that although drug treatment was continued 
the organism entered the blood stream for the third time, three 
days before death, which occurred on the 25th. day of illness.
This case illustrates two points, namely:
(1) The rapidity with which Sulphapyridine acts in cases
of bacteraemia irrespective of the degree to which 
the blood is invaded.
(2) The possible evolution of resistent strains of
pneumococci.
The ability of the bacterial cell to acquire a tolerance 
for a drug was demonstrated by Morgenroth and his co-workers ( i**' ) 
in their work with the pneumococcus and Optochin. They showed that 
passage of pneumococci four times through animals treated with 
Optochin caused the organisms to lose their sensitivity to the
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action of the drug. The results obtained by Sulphapyridine in 
bacteraemic cases show that in most cases the organisms were 
sensitive to the drug but it is possible that there do exist 
strains of pneumococci which are resistent to Sulphapyridine.
Summary.
Twenty-three bacteraemic cases of pneumococcal 
pneumonia were treated with Sulphapyridine and nine died, giving 
a death rate of 39 per cent.
The results in Type II. bacteraemic cases were en­
couraging as only one out of eleven died and the blood stream 
in several instances was invaded to a marked degree. The 
recovery of a patient suffering from Type II. pneumonia with
2,000 colonies of pneumococci per c.c. of blood is undoubted 
proof of the potency of the new drug.
The results in Type III. bacteraemic cases were frank­
ly disappointing as only one out of six recovered. The drug had 
no apparent effect on the bacteraemia in one patient, while four
of the remaining patients died after the bacteraemia had been
successfully overcome.
The effect of Sulphapyridine on Group IV. bacteraemic 
cases was also disappointing as it did not seem to influence the 
course of the bacteraemia in three of the six cases.
It is, however, of interest to note that no patient
who had a negative blood culture on admission to hospital
%
developed a bacteraemia during the course of treatment. 
Conclusions.
1. The death rate in bacteraemic cases of pneumococcal 
pneumonia treated with Sulphapyridine is high 
(39 per cent).
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2. Sulphapyridine has the power of overcoming the
bacteraemia even in cases of heavy invasion of 
the blood stream.
3. The presence of a negative blood culture in bacteraemic
cases, after 24 hours’ treatment with Sulphapyridine, 
tends to give a false feeling of security as regards 
the probable outcome of the illness.
4. The results of daily blood cultures indicate the
existence of drug resistent strains of pneumococcus.
5. Treatment of pneumococcal pneumonia with Sulphapyridine
prevents the entry of the pneumococcus into the blood 
stream, as shown by the results of daily blood cultures 
on pneumonia patients with negative blood cultures on 
admission to hospital.
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ANALYSIS OP FATAL CASES TREATED WITH SULPHAPYRIDINE.
It has been seen that in the series of 90 cases of 
pneumococcal pneumonia treated with Sulphapyridine that the case 
mortality was 13.3 per cent, a figure lower than most of the 
records for the years 1930-1937 in Knightswood Hospital, hut 
higher than some. While the figure is lower than that obtained 
in the control series in the investigation, the reduction in 
fatality rate is not so striking as that obtained by most other 
workers. The detailed analysis of the fatal cases reveals that 
these patients were very seriously ill and in several instances 
a pre-existing complication was present, which influenced the 
prognosis considerably. The most striking feature is the high 
mortality compared with figures published up to date, in Type III. 
pneumonia. Six of the twelve cases of Type III. pneumonia suc­
cumbed, and this would seem to indicate that when the drug is 
employed in the most virulent form of pneumonia, it has not come 
up to the expectations of the earlier workers.
Case I. C.N. Male aged 58 years, admitted to hospital on 
4th. day of illness, suffering from Type I. pneumonia, involving 
the lowest lobe of the right lung. He was sharply ill on admission 
Temperature 100 degrees, pulse rate 108 and respiration rate 34. 
Quality of heart sounds was very poor, indicative of myocardial 
weakness. The investigation of the case gave the following results
RESULT OP INVESTIGATION.
Day of Total Baso­ Eosino­ Neutrophils Blood
Illness Count phils phils M. J. St. S. L. Mon. Culture
4 th. 11,000 _ - 1 25 58 10 6 -
5th. 11,800 — - - - 23 68 7 2 -
6th. 12,400 - - 15 55 13 7 -
7th. 10,400 _ - - - 14 70 10 6
8th.
9th.
9,000 - — — 5 83 3 9
10 th. 
Died
6,000 — — • • 12 76 4 8
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As gauged by the type of infecting organism and extent 
of lung involvement, blood findings and absence of bacteraemia, 
the prognosis in this case should have been favourable. The 
general condition of the patient, however, gradually deteriorated 
and he was delirious for four days before death occurred. The 
drug was continued throughout the course of the illness, and 
while there was a decrease in the total leucocyte count, there 
was no sign of agranulocytosis. Blood culture was negative and 
remained so until death, and there were no signs of intolerance 
to the drug. Initially, the Schilling count indicated a favour­
able outcome and the progressive "shift to the right" on subse­
quent days seemed to substantiate this. The lung condition, 
however, in this instance was of secondary importance, and the 
toxaemia due to the pneumonia was not the striking feature of the 
case. There were no signs of a spread of the pneumonia, but the 
day before death, moist sounds were audible over the lower half 
of both lungs and pulmonary oedema ensued. In this case, the 
drug did not apparently have any beneficial effect and in the 
absence of a post mortem examination, death was attributed to 
Type I. lobar pneumonia, myocarditis, terminal pulmonary oedema.
Case II. W.B. Male, aged 37 years, admitted to hospital on 
5th. day of illness, suffering from Type II. pneumonia, involving 
the whole of both lungs with the exception of the right apical 
region. He was critically ill on admission and temperature was 
100.8 degrees, pulse rate 120, respiration rate 36. The results 
of investigation were as follows.
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RESULT OP INVESTIGATION.
Day of Total Baso­ Eosino­ Neutrophils Blood
Illness Count phils phils M. J. St. S. L. Mon. Culture
5 th. 26,000 - - 1 7 54 27 5 6 58 colonies
6th. 30,000 2 52 39 5 2
per c.c.
7th.
Died 31,000 - - 2 36 46 9 7 —
From the onset, the prognosis in this case was very 
serious, as can be observed from the extent of lung involvement 
and the degree of bacteraemia. While the total white count in­
dicated a satisfactory response to the infection, the Schilling 
count showed an extreme "shift to the left", the primitive cells 
in the blood totalling 62 per cent. With treatment, the patients 
general condition improved slightly as did the blood picture, and 
the bacteraemia was successfully combatted, but he collapsed on 
the 7th. day of illness and died.
Case III. W.H. Male, aged 60 years, admitted to hospital 
on 3rd. day of illness, suffering from Type II. pneumonia, involv­
ing the lower lobe of the left lung, and also suffering from 
auricular fibrillation. He was sharply but not critically ill on 
admission. Temperature 102.2 degrees, pulse rate 132, respiration 
rate 36. Investigation yielded the following results.
RESULT OF INVESTIGATION.
Day of Total Baso­ Eosino­ Neutrophils Blood' '
Illness Count phils phils M. J. St. S. L. Mon. Culture
3rd. 12,000 _ _ 4 35 55 3 3 -
4th. 12,000 - - 4 32 48 10 6 -
5 th. 13,000 - - 2 34 40 14 10 -
6th. 13,000 — - 1 19 59 10 11
7th.
11th.
Died
12,000 1 10 70 9 10
In this case, the prognosis was considered to be reason­
ably good. The temperature, pulse and respiration rates settled
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after two days’ treatment with Sulphapyridine, and pulse steadied 
with the use of digitalis. Blood culture was negative, and 
Schilling count showed a progressive ’’shift to the right”. The 
lung condition did not show signs of resolution, but as the 
patient was having nausea and vomiting, the drug was stopped on 
the 7th. day of illness. The temperature began to rise again and 
the consolidation of the lower lobe of the left lung was unchanged. 
The temperature remained irregular for the next three days and on 
the 11th. day of illness the patient collapsed suddenly and died.
Case IV. H.D. Male, aged 59 years, admitted to hospital on 
5th. day of illness, suffering from Type III. pneumonia, involving 
the entire right lung. He was critically ill on admission. 
Temperature was 100.4 degrees, pulse rate 128, and respiration 
rate 36. The result of investigation is as follows.
RESULT OF INVESTIGATION.
Day of Total Baso­ Eosino­ Neutrophils blood
11lne s s Count phils phils M. J. St. S. L. Mon. Culture
5th. 8,000 - - 11 44 32 2 11 - 1 colony 
per c.c.
6 th. 
Died
7,600 •• 21 54 24 • 2 **
The prognosis in this case was hopeless as indicated by 
the above findings. The patient did not respond to treatment.
Case V. J.S. Male, aged 42 years, admitted to hospital on 
5th. day of illness, suffering from Type III. pneumonia, involving 
the lower lobes of both lungs. He was critically ill on admission. 
The temperature was 99 degrees, pulse rate 124, and respiration 
rate 32.
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RESULT OF INVESTIGATION.
Day of ”Tb€aV baso­ Eosino­ Neutrophils blood
Illness Count phils phils M. J. •
-pCO
S 1 L. Mon. Culture
5th. 10,000 - - 11 22 50 13 4 4 380 colonies 
per c.c.
6th. 12,000 - - 2 19 61 13 3 1
Vth. 14,000 - - 1 10 55 29 3.5 1.5
8th.
9th.
Died
20,000 3.5 14 46 30 3.5 3
Here again, the prognosis was very serious as seen by 
the bacteraemia and Schilling count. While the invasion of the 
blood was overcome, and the total leucocyte count rose on suc­
cessive days, at no time did the patient look like recovering and 
he gradually sank into the typhoid state. The pneumonic process 
spread to the adjacent lung tissue in both lungs before death.
Case VI. T.M. Male, aged 52 years, admitted to hospital on 
8th. day of illness, suffering from Type III. pneumonia, involving 
the entire left lung. He also was critically ill on admission.
The temperature was 99.8 degrees, pulse rate 102, and respiration 
rate 40.
RESULT OF INVESTIGATION.
Day of Total1Baso­ Sosino- Neutrophils Blood
Illness Count phils phils M. J. St. S. L. Mon. Culture
8th. 4,000 - - 2 15 46 14 19 4 110 colonies 
per c.c.
9th. 3,200 - - 1.5 12 54 14 7 1.5 -
10 th. 
11th. 
Died
4,000 2 14 55 15 10 4
From the above data, the prognosis in this case was very 
grave. Although the blood became sterile after 24 hours, the 
drug had no apparent effect on the course of the illness. Post 
mortem examination revealed lobar pneumonia involving the base of 
the right lung and the entire left lung, the lower lobe of which 
w&s necrotic and permeated with thick muco-pus.
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Case VII, T.McK. Male, aged 59 years, admitted to hospital 
on 2nd. day of illness, suffering from Type III. pneumonia, in­
volving the entire left lung. In addition, the patient had 
auricular fibrillation and he was critically ill. The temperature 
was 101.2 degrees, pulse rate 104, respiration rate 44.
RESULTS OP INVESTIGATION.
Day of Total baso­ Eosino­ Neutrophils Blood
Illness Count phils phils M. J. St. S. L. Mon. Culture
2nd. 15,000 _ 3 56 30 9 2 +
3rd. 14,000 - - 1 16 52 21 8 2 +
4th. 12,000 - - - 3 62 23 10 2 4-
5th. 10,000 — — 4 43 44 8 1 20 colonies 
per c.c.
6 th.
7th.
Died
18,000 10 56 23 10 2 320 colonies 
per c.c.
The prognosis from the onset was very serious. Clini­
cally there was a slight improvement in the patient's general 
condition after two days in hospital, but he became wildly 
delirious and did not tolerate the drug well. The total leucocyte 
count became gradually lower until two days before death, and the 
Schilling count showed a marked "shift to the left”. Although 
the patient was admitted on the 2nd. day of illness, he failed to 
respond to treatment and the organism multiplied in the blood.
Case VIII. D.H. Male, aged 72 years, admitted to hospital 
on 4th. day of illness, suffering from Type III. pneumonia, in­
volving the left base and the entire right lung with the exception 
of the apex. He was critically ill on admission. The temperature 
was 101.2 degrees, pulse rate 136, and respiration rate 46.
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RESULT OP INVESTIGATION.
Day of Total Baso­ Eosino­ Neutrophils 51663 -
Illness Count phils phils M. J. St. S. L. Mon. Culture
4th. 10,400 _ _ 1 13 50 25 8 3
5th. 19,600 - - - 3 66 22 2 7
6 th. 11,000 - - - 1 43 47 6 3
7th. 11,000 - - - - 20 64 11 5
8 th. 
Died
12,400 — — — — 17 73 3 7 -
The prognosis again was very grave as indicated by the 
patient's age, extent of involvement and Schilling count.' One 
interesting feature in contrast to Case VII. was that the blood 
culture was negative on admission and remained so throughout the 
illness. There was a gradual deterioration in the patient's 
general condition and he died on the 8th. day of illness.
Case IX. P.C. Male, aged. 47 years, admitted to hospital on 
4th. day of illness, suffering from Type III. pneumonia, involving 
the lower two lobes of the right lung and the base of the left 
lung. The initial temperature was 99.8 degrees, pulse rate 144, 
and respiration rate 56.
RESULT OF INVESTIGATION.
Day of ’ ToEaT Baso­ Eosino­ Neutr<DphiIs ----Slood
Illness Count phils phils M. J. St. S. L. Mon. Culture
4 th. 3,800 - - 3 25 49 6 18 - 5000 colonies 
per c.c.
5th. 4,600 - - 4 46 30 4 13 3 +
6 th. 11,000 - - 2 20 52 17 7 2 -
7th. 14,000 - • - 5 40 46 8 1 -
8th. 18,000 - - - 3 30 54 10 3 -
9th. 24,000 - - - 3 29 56 5 7
13 th. 30,000 - 1 3 27 55 6 8 -
16 th. 
21st. 
Died
25,000 1.5 33 55 4 7
This patient looked as if he would die shortly after 
admission to hospital, and the severity of the illness was con 
firmed by the extreme degree of bacteraemia accompanied by a
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leucopenia and Schilling count. The following day the blood 
culture was still positive but the plate count was negative.
On subsequent days the blood remained sterile. The leucopenia 
gradually improved and after a few days1 treatment there was a 
marked leucocytosis accompanied by a wshift to the right” in the 
Schilling count. In spite of these facts, the patient continued 
to look critically ill and there were no signs of resolution in 
the lungs. On the 10th. day of illness the drug was discontinued 
as he was beginning to show signs of intolerance. The temperature, 
pulse rate and respiration rate remained normal and the blood 
culture sterile. He developed a generalised purpuric eruption 
and his general condition gradually deteriorated. He died on 
the 21st. day of illness.
Case X. D.C. Male, aged 67 years, admitted to hospital on 
the 8th. day of illness, suffering from Type VI. pneumonia, in­
volving the entire right lung, and also suffering from auricular 
fibrillation. Initial temperature was 99.8 degrees, pulse rate 
110, and respiration rate 36.
RESULT OP INVESTIGATION.
Day of Total Baso­ Eosino­ Neutrophils . . Blood
Illness Count phils phils M. J. St. S. L. Mon. Culture
8 th. 18,000 _ _ 1 4 28 56 8 2 +■
9th. 17,000 - - - 1 26 63 6 4
10th. 16,000 - - - 3 36 56 3 1
11th. 16,000 — — - 10 50 36 4 — 20 colonies 
per c.c.
12 th. 
Died
16,000 — — ** 17 46 31 5 1 400 colonies 
per c.c.
This patient was critically ill and he was in a very 
debilitated condition. As indicated by the blood picture and 
bacteraemia, the drug did not seem to have any apparent effect 
on the course of the illness, and although the heart steadied 
with the use of digitalis, the sounds were of very poor quality 
and he gradually sank into the typhoid state and died.
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Case XI. A.K. Female, aged 53 years, admitted to hospital 
on 2nd. day of illness, suffering from Type VIII. pneumonia, in­
volving entire right lung with the exception of the apex. The 
patient, in addition, suffered from valvular disease of the heart. 
The initial temperature was 100.4 degrees, pulse rate 140, and 
respiration rate 50.
RESULT OF INVESTIGATION.
Day of Total baso­ Sosino- NeutropHils Blood
11lne s s Count phils phils M. J. St. S. L. Mon. Culture
2nd. 20,000 _ _ 3 18 50 20 7 2 +
3rd. 18,000 - - - 6 54 31 5 4 ♦
4th. 10,000 - - - 1 20 72 6 3 +
5th. 11,000 - - - 1 12 67 10 10 +
6th. 14,000 - - - - 5 74 20 19
7 th. 15,000 - - - - 5 67 16 12 ♦
8th. 30,000 - - - - 11 69 14 6 +
9 th. 40,000 - - - - 7 83 6 4 +
10th.
Died
50,000 — — — — 4 85 6 5
Blood culture was positive throughout the illness, but 
as plate counts were not performed in this case, it was not known 
if the organism multiplied in the blood stream. While there was 
an initial leucocytosis, the Schilling count showed a marked 
1 shift to the left’1, the percentage of primitive white cells in 
the blood being 71. Sulphapyridine was administered throughout 
the illness, which was treated from the 2nd. day. Although the 
blood culture remained positive, there was no spread of the in­
fection, and the physical signs over the affected lung remained 
those of massive consolidation, without resolution or spread.
The leucocyte count rose to 40,000 the day before death and there 
was also a rise in temperature. The patient died on the 10th. 
day of illness.
Post mortem examination revealed a massive consolidation 
of the right lung with the exception of the apex, and the lung 
tissue was in a state of red hepatisation, i.e., the pathological
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condition in the lung had remained stationery since the commence­
ment of drug treatment.
This finding, together with the large percentage of 
cases with delayed resolution, would seem to indicate that 
Sulphapyridine interferes with the normal pathological process 
in lung tissue infected with the pneumococcus.
Case XII. A.C. Male, aged 63 years, admitted to hospital 
on 3rd. day of illness, suffering from Type VIII. pneumonia, in­
volving the lower lobe of the left lung. He also was suffering 
from auricular fibrillation, and prior to the onset of the pneu­
monia, had not been well for several months following a head in­
jury caused by a road accident. An indefinite history of lethargy 
attributable to the accident was obtained from his wife, but 
examination failed to reveal any evidence of cerebral injury.
He was critically ill on admission to hospital, and the initial 
temperature was 100.6 degrees, pulse rate 144, and respiration 
rate 44.
RESULT OP INVESTIGATION.
Day of TottT Baso­ Eosino­ Ne1utrophils ---- Blood
Illness Count phils phils M. J. St. S. L. Mon. Culture
3rd. 25,000 - - - 1 28 64 4 3 2000 colonies 
per c.c.
4 th. 12,000 - - - 1 14 72 9 4 -
5th. 12,000 - - - - 8 70 12 10 -
7 th. 18,000 - - - - 4 58 24 14
8th. 25,000 - - - - 5 68 15 12
9th. 50,000 — - — — 13 63 9 15 60 colonies 
per c.c.
10 th. 55,000 - - - - 6 88 3 3 -
11th. 25,000 - 1 - - 5 80 9 6 -
12 th. 12,000 - 1 - - 5 79 6 10 -
13 th. 
25th. 
Died
13,000 2 5 66 11 18
4*
The leucocyte response both as regards quantity and 
quality of leucocyte was good, but the blood stream showed a
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massive invasion. After 24 hours* treatment with Sulphapyridine, 
the blood stream was sterile and his heart was becoming more 
regular with the administration of digitalis. He was still very 
lethargic and the cyanosis was very marked. As this case was 
encountered early in the investigation, it was decided to dis­
continue the drug after 72 hours’ treatment because of the cyan­
osis and lethargy. Coincident with the stopping of the drug, his 
temperature began to rise again and his general condition became 
worse. Blood culture was repeated before drug treatment was re­
commenced, and it was found that 1 c.c. of blood contained 60 
colonies of Type VIII. pneumococci. Again the blood became 
sterile within 24 hours of restarting treatment.
His general condition failed to improve and the process 
in the lungs seemed neither to progress or regress, so it was 
decided to continue the drug indefinitely in view of the above 
findings. He tolerated the drug well and the temperature remained 
normal. Blood cultures were performed at intervals and proved to 
be negative until the 22nd. day of illness, when the temperature 
began to rise again and there was an extension of the pneumonia 
to the other lung and a re-entry of the pneumococcus into the 
blood stream. The blood culture remained positive until death, 
which occurred on the 25th. day of illness.
Prom the onset, the prognosis was very serious, because 
of the pre-existing complications. The ability of the drug to 
cope with the pneumococcal infection was seen by the rapid dis­
appearance of the organism from the blood stream in spite of a 
very heavy infection.
This case illustrates two points, namely:
(1) The necessity of continuing the drug after the initial
fall in temperature, pulse and respiration rates.
(2) The possibility of the pneumococcus becoming resistent
to Sulphapyridine.
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Conelusions.
1. Eleven Type I. infections were treated with Sulpha-
pyridine and only one proved fatal. Unfortunately, 
the cause of death in this instance was imperfectly 
understood, the outstanding features of the case were 
the myocardial weakness and progressive deterioration 
in the patient*s general condition. Blood culture 
remained negative, and the blood picture was not 
typical of an acute toxic illness.
2. Thirty-four cases of Type II. pneumonia were treated
with Sulphapyridine and only two deaths occurred 
giving a fatality rate of 5.9 per cent. This result 
is very significant, as the clinical findings in the 
two fatal cases showed that one of the patients died 
of heart failure after the acute phase of the illness 
had been successfully overcome, while in the other 
case the prognosis was very grave as shown by the 
results of investigation.
3. The results in the Type III. infections were frankly
disappointing - only six of the twelve cases so 
treated recovered. Of the fatal cases, the duration 
of illness at the time when treatment was instituted 
varied from the second to the eighth day. The clinical 
and laboratory findings, however, indicated the severe 
nature of the illness. The average age of the patients 
was 53.5 years - the extremes being 42 and 72 years, 
while the average involvement of lung tissue was always 
two lobes or more. Three of the patients had a marked 
leucopenia but the initial count varied from 3,200 to 
28,000 per c.c. of blood. The Schilling count showed
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a marked "shift to the left", the average percentage 
of primitive white cells in the blood being 72 per 
cent. Five of the six patients had a bacteraemia, 
and in four instances the bacteraemia was successfully 
combatted, while in the remaining case the organism 
actually multiplied in the blood. It is possible that 
the result in this last case was caused by an inadequate 
concentration of the drug in the blood stream due to 
excessive vomiting.
4. Three deaths occurred in thirty-three Group IV. cases 
treated with Sulphapyridine. All of these patients 
suffered from cardiac trouble and either endocardial 
or myocardial, and all of them had a bacteraemia. It 
is of interest to note that the drug had no apparent 
effect on the bacteraemia in two of the cases.
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TOXIC MANIFESTATIONS OF SULPHAPYRIDINE TREATMENT.
The ideal chemotherapeutic agent is one which will 
exert its maximum effect and at the same time have a low toxicity 
for the human subject, or better still, one which will prove non­
toxic and be slowly excreted, so enabling a large initial dose to 
be given, forming a store in the body from which steady absorption 
can take place. This would result in the maintenance of an ade­
quate concentration of the drug in the blood.
While Sulphapyridine as a therapeutic agent falls short 
of the ideal, it nevertheless has the advantage, not only of 
exerting a powerful action on pathogenic bacteria, but also of 
being relatively non-toxic. This relative absence of toxicity 
was first noticed by Evans and Gaisford (1938) who, in their 
clinical trial of Sulphapyridine in pneumonia, reported the 
occurrence of nausea and vomiting and cyanosis as the only un­
toward effects of the administration of the drug. More serious 
signs of toxicity attributable to Sulphapyridine therapy, for 
example, drug fever, haematuria,jaundice, anaemia and agranulo­
cytosis, have been reported by other workers, but these have been 
the exception rather than the rule.
During this investigation, the occurrence of cyanosis, 
nausea and vomiting were the only evidence of any toxic property 
of Sulphapyridine. Since vomiting was supposed to be attributable 
to a direct irritation of the gastric mucosa, all other oral 
mixtures, with the exception of bismuth and soda in teaspoonful 
doses, were stopped and the drug, which was supplied in tablet 
form, was administered crushed up in milk or orange juice. This 
procedure did much to obviate the somewhat trying, but fortunately 
not dangerous occurrence of vomiting. At the time of this in­
vestigation, the solution of the sodium salt of Sulphapyridine 
for intravenous use was not on the market, and the only alternative
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method of administering Sulphapyridine was by intramuscular 
injection of a suspension of the drug in olive oil. This pro­
cedure, however, had only to be resorted to in four instances 
when the vomiting was severe. It was observed in these cases, 
that the vomiting was not entirely checked, showing that this 
symptom was not wholly due to the direct irritation of the gastric 
mucosa and that probably the action was central. While vomiting 
did much to make the patient feel miserable and must be regarded 
as an indication of toxic action, it was only looked on as serious 
because it interfered with the administration of the drug. In 
the absence of estimations of the concentration of the drug in 
the blood, it was feared that the blood concentration in these 
cases must have been inadequate.
While a varying degree of cyanosis was a frequent 
occurrence in patients treated with Sulphapyridine, in only one 
case was the cyanosis severe. This case occurred early in the 
series before much was known regarding the toxicity of the new 
drug. Because of a fear of a toxic reaction, Sulphapyridine 
treatment was stopped only to be followed by a secondary rise 
in temperature and a recurrence of the bacteraemia, which had 
been previously checked, consequently, treatment was restarted.
The cyanosis reappeared but did not have a sufficiently deleterious 
effect to warrant discontinuance of the drug. Consequently, 
cyanosis was not looked on as an alarming toxic manifestation 
of Sulphapyridine treatment since the result of withdrawal of 
the drug greatly outweighted the ill effects attributable to it.
The following Table I. details the occurrence of these 
toxic manifestations.
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TABLE I.
No.of cases with
Vomiting Cyanosis
Mild 40 50
Moderate 20 19
Severe 4 1
Total 64 70
It may be seen from Table I. that 64 or 71 per cent 
of patients treated with Sulphapyridine suffered from nausea 
and vomiting while 70 or 77 per cent showed varying degrees of 
cyanosis during treatment.
No cases of drug fever, haematuria, anaemia or jaundice 
occurred in this series. Two patients were jaundiced on admission 
to hospital but the jaundice gradually disappeared during treat­
ment. The course of the leucocyte count on patients under treat­
ment has been discussed in Chapter II. and there was no evidence 
of agranulocytosis.
It may be concluded, from the experience of the treat­
ment of this small series of patients, that Sulphapyridine is 
relatively free from toxicity for the human subject.
DOSAGE OF SULPHAPYRIDINE.
Whitby (1938) has shown that despite its insolubility, 
Sulphapyridine is absorbed rapidly into the blood stream, so he 
advocates that patients undergoing Sulphapyridine treatment should 
receive a large initial dose, followed by smaller doses, to main­
tain an adequate concentration of the drug in the blood stream. 
Long and Bliss (1939), however, have pointed out that the ab­
sorption of Sulphapyridine is such a variable factor that the 
only satisfactory method of establishing a rational system of 
dosage is by estimations of the concentration of the drug in
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the blood. They recommend that a concentration of 4 to 6 milli­
grams per cent during the first three or four days of treatment 
is adequate in moderately ill patients, whereas in more severely 
ill patients, especially if a bacteraemia is present, a concentra­
tion of 7 to 10 milligrams per cent should be established as 
quickly as possible. Since estimations of the concentration of 
Sulphapyridine in the blood were not carried out in this investi­
gation, the dosage had to be gauged according to the severity of 
the illness as estimated by the prognostic factors discussed in 
Chapter III. of this thesis.
Evans and Gaisford (1938) suggested as a routine treat­
ment an initial dose of 2 grammes (4 tablets) followed by a four 
hourly dose of 1 gramme. At the beginning of this investigation, 
the above scheme was adopted but latterly, in severe cases, the 
initial dose of 2 grammes was continued for several days. In 
other words, an attempt was made to obtain an effective concentra­
tion of the drug in the blood stream as quickly as possible and 
this was maintained until there were signs of clinical improvement.
The duration of treatment depended on the response of 
the patient and it was found in the early stages of the investi­
gation that the temperature reading was an inadequate guide to 
the patient’s response. Other factors had to be taken into con­
sideration and these were:- the pathological condition of the 
lungs, the presence or absence of a bacteraemia and the Schilling 
count. Generally speaking, the drug was continued for two or 
three days after the initial fall in temperature, in view of the 
finding that too early stoppage of the drug treatment was followed 
by an exacerbation of the disease.
106
»107
STATISTICAL TESTS.
I. The statistical significance attaching to each of
the observed differences tabulated in Chapter III. Table VIII. 
of the text, has been assesses in the usual manner by calculat­
ing the value of wt" - the ratio of the difference in means to 
the estimated standard deviation, the latter being calculated 
from the sum of the squares of the deviations from the individual 
means i.e.
<r -
and t - ( * )
Sx2
nl t n2 - 2
nl - n2
nl +
In illustration of this point, is submitted the follow­
ing calculation in respect of age of patient in the two groups - 
serum and non-serum treated.
A • Age
Non-serum 
treated cases.
Serum 
treated cases
S(A) 1,464 785
S(A2) 65,526 26,097
I 37.5385 28.0357 *
I.S(A) 54,956.3640 22,008.0245
Sum of Squares 14658,,6115
Variance 225 5171
Estimated Standard 
deviation (<T )
15, 0172
Difference of means (d) 9.5028
V<r 0,6328
t 2,55
As a criterion of significance, a value of t * 2.04 
may be taken (P s .05) and for greater safety t • 2.4 (P - .02) 
or t * 2.75 (P * .01) indicate limits outwith which a difference
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is unlikely to have arisen by chance. The actual value of "t” 
for each variable considered is tabulated below
Variable t
Age of patient 2.55 x
Day of illness 4.26 x
Number of lobes involved 0.62
Temperature 3.25 x
Pulse rate 1.39
Respiration rate 1.70
Total white cell count 1.34
Myelocytes and Juveniles 1.05
Stab cells 1.23
Segmented Polymorphonuclears 0.06
Lymphocytes 0.76
Monocytes 0.49
The value of t in respect of age differences in the 
two groups is 2.55 giving a value of P = 0.02 which is signifi­
cant. For day of illness on admission to hospital and initial 
temperature the differences are more highly significant, the 
value P being less than 0.01.
II. The results were treated in two ways, (1) as a 2 x 2
fold and (2) as a 3 x 2 fold table, in the latter instance, the 
recoveries being divided to show those terminating favourably by 
crisis and lysis separately. The Tables are -
TABLE I.
Non-serum
treated
patients
Serum treated 
patients Total
Deaths 11 6 17
Recoveries 28 22 50
39 28 67
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TABLE II.
Recovery
by
Non-serum 
treated 
patients
Serum treated 
patients
Total
Deaths 11 6 17
(Lysis 7 8 15
(Crisis 21 14 35
39 28 67
For table I, ^C2 * 0.395 and P lies between 0.70
and 0.50. With Yates correction  ^is reduced to 0.118 and
P increased to 0.75
For Table 11^, 2 = 1.16 and for n « 2 P » 0.55
— g
For a 2 x 2 fold table *V 2 - n ~ ). . N—
A* (a^c) (b-fd) (a+b) (c+d)
where a, b, c, d are the frequencies in each of the four cells
and N = total observations thus:-
Non-serum
treated
patients
Serum treated 
patients. Total
Deaths a b a b
Recoveries c d c + d
a + c b + d N
With Yates1 correction - 
2X N 2(ad - be - £) N (a+b)(aVc) (b+d)(c *d)
For a 3 x 2 fold table ^  2 is obtained from
,2(x - xf )' 
x«- 3
where x = the actual and x1 * the independence frequencies in 
each of the cells; and the corresponding value of P is obtained 
by entering Fisher’s table of ^  2 with degrees of freedom * 2
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III. An analysis of variance was made using the three
groups of patients - deaths and recoveries by lysis and crisis, 
as well as an analysis of the two groups - deaths and recoveries. 
The values of z and t are detailed below:-
z t
Age of patient 1.1215 4.2346
Day of admission 0.1955 0.9884
Number of lobes involved 1.3973 4.8487
Temperature 0.2464 0.6949
Pulse Rate 0.3059 1.9344
Respiration rate 0.3367 1.9202
Total white cell count 0.7062 2.7803
Myelocytes and Juveniles 1.3974 5.7327
Stab cells 0.4321 1.3823
Segmented Polymorphonuclears 1.0973 4.2706
Lymphocytes 0.3350 2.7437
Monocytes 1.0762 4.1805
Day of termination 0.6729 0.3291
For the three groups and for n^ ■ 2 and ^  * 60,
the value of z corresponding to the five per cent level of
significance is 0.5738, to the one per cent level 0.8025 and 
to the one per thousand level 1.0248. Using these values, it 
will be seen that the differences in respect of age of patient, 
number of lobes involved, the number of segmented polymorpho- 
nuclears, myelocytes, juveniles and monocytes in the blood, 
would occur by chance less often than once in a thousand trials; 
and the total white cell count shows a difference which reaches 
the 5 per cent level and is, therefore, also probably Indicative
of a real divergence between the groups.
Considering only the two groups i.e. deaths and
recoveries, the significance of each of the divergencies has
to be judged against the following values of t (for n * 40 as
the closest value given in Fisher1s table)
P * 0.05 for t » 2.021
P - 0.01 for t - 2.704
P - 0.001 for t » 3.551
Ill
The differences in respect of age of patient, number 
of lobes involved, the number of segmented polymorphonuclears, 
myelocytes, juveniles and monocytes are all highly significant, 
while the differences in respect of total white cell count and 
number of lymphocytes, coming between the one per cent and one 
per thousand level, are also significant.
The remaining differences are such as might well have 
arisen purely by chance and, therefore cannot be regarded as 
factors of any importance in indicating the probable outcome of 
the disease.
“V 2IV. Using Yates* correction /v, calculated as shown
previously = 4.2133, the corresponding value of P (for n ■ 1)
• 0.04 and is thus just outwith the probable range of a chance 
deviation.
V. Again using Yates* correction )C  ^“ 5.5 and the
corresponding value of P * 0.02 showing that the difference is 
statistically significant.
112
COMPLETE ANALYSIS OP OBSERVED DATA.
II.
N.S. - Non-Serum treated cases. S. = Serum treated cases.
S.P. = Sulpha pyridine treated cases. C. = Controls, i.e. N.S. + S.
D. ■ Deaths. R. = Recoveries.
Age.
N.S. S. S .P. C. Total. Grand.
D R D R D R D R D R Total.
10- 4 1 3 5 8 8
15- 3 1 8 19 1 11 1 30 31
20- 4 5 8 9 17 17
25- 1 4 1 1 10 2 5 2 15 17
30- 3 1 1 8 1 4 1 12 13
35- 2 2 1 3 1 8 3 5 4 13 17
40- 1 1 4 1 1 5 6
45- 1 3 1 3 4 1 7 8
50- 1 4 2 2 5 3 4 5 9 14
55- 4 1 3 8 4 1 7 9 16
60- 3 1 2 2 3 1 5 3 8
65- 1 1 1
70- 1 1 1
11 28 6 22 12 78 17 50 29 128 157
Lobes 
Involved.
N,>S. 2>, S.P. C • Total Grand
D R D R D R D R D R Total
1 1 23 1 11 3 48 2 34 5 82 87
2 5 5 5 9 3 23 10 14 13 37 50
3 5 2 5 6 5 2 10 8 18
4 1 1 1 1 2
11 28 6 22 12 78 17 50 29 128 157
Blood N.S. 2>. S.P. C• Total Grand
Culture. D R D R D R D R D R Total
♦ 4 2 2 3 9 14 6 5 15 19 34
- 7 26 4 19 3 64 11 45 14 109 123
11 28 6 22 12 78 17 50 29 128 157
Day of 
Admission.
N .S. 2i. S,,P. C. Total Grand
D R D R D R D R D R Total
1 1 2 2 1 2 1 4 5
2 3 5 2 6 2 10 5 11 7 21 28
3 3 3 1 10 2 19 4 13 6 32 38
4 2 7 2 4 3 24 4 11 7 35 42
5 2 5 3 14 2 5 5 19 24
6 1 6 3 1 6 1 9 10
7 1 3 1 4 4
8 1 2 3 1 2 4 6 _
11 28 6 22 12 78 17 50 29 128 157
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COMPLETE ANALYSIS OP OBSERVED DATA
N.S. « Non-serum treated cases. S. = Serum treated cases.
S.P. » Sulpha pyridine treated cases. C. = Controls, i.e. N.S. + S.
D. * Deaths. R, a Recoveries.
Type of 
Pneumococcus
N.S. S. S .P. C. Total Grand.
D R D R D R D R D R Total
I. 1 12 11 1 10 1 23 2 33 35
II. 6 7 6 10 2 32 12 17 14 49 63
III. 1 6 6 1 7 6 13
IV. 1 2 1 1 2 3
V. 1 1 1 2 2
VI. 1 1 1 1 2 1 3
VII. 7 7 7
VIII. 3 2 4 3 2 7 9
IX. 2 2 2
XI. 1 1 1 1
XIII. 2 2 2
XIV. 1 1 1 2 2
XVIII. 2 2 2 2
XIX. 1 1 1 2 2
XX. 1 2 1 3 3
XXII. 2 2 2
XXIV. 1 1 1
XXIX. 1 1 1
XXXIII. 1 3 1 4 4
11 28 6 22 12 78 17 50 29 128 157
Total 
white 
Cell Count.
N.S. a S ,P. G . Total Grand
D R D R D R D R D R Total
2000 1 1 1
4 2 1 1 2 3 1 4
6 2 2 1 1 3 3 3 3 6
8 2 1 2 1 3 2 3 3 6 9
10 2 1 3 8 3 3 11 14
12 3 4 1 1 1 4 4 5 5 9 14
14 2 1 4 1 5 1 6 2 11 13
16 1 4 5 1 4 1 9 10
18 3 1 1 8 4 1 12 13
20 2 2 1 1 1 3 3 3 4 6 10
22 1 7 1 8 8
24 2 1 12 2 1 14 15
26 1 1 1 1 1 2
28 1 1 4 2 6 6
30 1 3 1 5 1 4 1 9 10
32 1 1 5 2 7 7
34 2 2 2 4 6 6
36
38 3 3 3
40 2 2 2 4 4
42 1 1 1
60 1 1 1 1
11 28 6 22 12 78 17 50 29 128 157
M'
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COMPLETE ANALYSIS OP OBSERVED DATA.
N.S. s Non-Serum treated cases. S. = Serum treated cases.
S.P. * Sulpha pyridine treated cases. C. ** Controls i.e. N.S. ♦ S.
D. * Deaths. R. = Recovery.
Temperature.
N.S. S . S .P. C. Total Grand.
D R D R D
*
R D R D R Total.
97 1 1 1 1
2
4 1 1 1 1
6 1 1 1
8
98
2
4 1 1 1
6
8
99 1 1 1
2 1 2 1 3 3
4 1 1 2 1 1 3 4
6 2 2 2
8 1 3 1 1 4 1 5
100 1 1 2 1 2 2 4
2 3 5 3 8 8
4 1 2 2 1 2 3 5
6 1 1 1 6 1 1 2 7 9
8 2 2 2 4 4
101 1 1 1 7 2 1 2 8 10
2 1 3 1 1 2 3 2 4 4 7 11
4 1 1 5 2 7 7
6 1 1 2 1 2 3 2 3 4 7
8 1 2 1 6 3 1 9 10
102 4 4 6 8 14 14
2 1 3 1 3 4
4 2 6 2 8 10 10
6 1 1 1 2 6 2 3 2 9 11
8 3 1 4 4 4
103 1 1 6 1 1 1 7 8
2 1 1 1 1 2 1 2 3
4 1 1 1
6 1 1 1 1 1 1 2
8 1 1 1
104
2 1 1 2 1 1 1 3 4
4 1 1 1
11 28 6 22 12 78 17 50 29 128 157
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COMPLETE ANALYSIS OP OBSERVED DATA.
N.S. = Non-Serum treated cases. S. * Serum treated cases.
S.P. * Sulpha pyridine treated cases. C. * Controls, i.e. N.S. + S.
D. 3 Deaths. R. = Recoveries.
Pulse 
Rate.
N,,S. S • S .P. Ci Total Grand
D R D R D R D R D R Total.
80 1 1 1 1
84
88 2 2 2
92 1 1 1 3 1 2 1 5 6
96 2 5 2 7 7
100 3 3 3
104 1 1 1 5 2 1 7 8
108 3 1 1 2 7 1 4 3 11 14
112 1 5 1 2 9 2 7 2 16 18
116 1 5 1 7 1 6 1 13 14
120 3 1 6 2 7 1 9 3 16 19
124 1 3 1 1 1 7 2 4 3 11 14
128 1 3 1 4 1 9 2 7 3 16 19
132 2 1 1 5 2 1 3 6 9
136 3 1 1 2 1 6 4 3 5 9 14
140 1 1 2 1 1 3 4
144 2 2 2
148 1 1 1
152
156 1 1 1 1
160 1 ..L . 1 1 1
11 28 6 22 12 78 17 50 29 128 157
Respiration 
Rate.
N.S. S • S .P. C. Total Grand
D R D R D R D R D R Total.
24 2 1 2 3 3
26 1 1 1 2 3 3
28 1 6 1 4 10 2 10 2 20 22
30 3 4 3 7 7
32 3 8 2 1 1 9 5 9 6 18 24
34 1 1 4 1 1 5 6
36 2 4 1 7 5 17 3 11 8 28 36
38 1 1 1 1 1 2
40 2 4 1 5 1 15 3 9 4 24 28
42 2 2 2
44 2 1 6 2 1 8 9
46 1 1 1
48 1 1 5 2 2 5 7
50 1 1 1 1 1 1 2 2 4
52 2 2 2
54
56 1 1 1
11 28 6 22 12 78 17 50 29 128 157
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